Final programme

Transcription

Final programme

Final programme
EUROPEAN SOCIETY FOR
PEDIATRIC DERMATOLOGY
Maison de la Mutualité,
PARIS, FRANCE
Proud to work for
rare disease
populations
with great
needs.
A Clinical-stage Biotechnology Company
At the Forefront of Therapies for Rare and Orphan Diseases®
P/NPS/01 0161/EU5-16
TABLE OF CONTENTS
Welcome Address 4
Committees 8
Scientific Programme Schedule at a Glance 10
Detailed Programme
Wednesday, 25th May 2016 13
Thursday, 26 May 201614
th
Friday, 27th May 2016 17
Saturday, 28th May 2016 20
Index of Chairs & Speakers 22
Posters 23
This programme
is also available
on the web app:
www.espd2016.com
Sponsored by:
Exhibition Floor Plan 33
List of Exhibitors33
Company Profil
es34
Social Networking Programme 37
General Information & Access38
Registration 40
Accommodation 42
Congress Center Floor Plan44
Sponsors Acknowledgement 47
CONTACT
CONGRESS OFFICE
ESPD 2016 - MCI France - 24, rue Chauchat 75009 Paris - France
Phone: +33 1 53 85 82 56 Fax: +33 1 53 85 82 83
FOR SPECIFIC QUESTIONS REGARDING:
General information: info@espd2016.com
Registration & Accommodation: registration@espd2016.com
Exhibition & Sponsorship: exhibition@espd2016.com
Abstract & scientic programme: abstract@espd2016.com
Website: www.espd2016.com
13th ESPD Congress - PARIS, 26-28 May 2016
3
WELCOME ADDRESS
Dear colleagues, dear friends,
WELCOME TO PARIS!
It is a great pleasure and honour for all members of the French
Society of Paediatric Dermatology to welcome you for the 13th
Congress of the European Society for Pediatric Dermatology
(ESPD), which will be held May 26 to 28, 2016.
The organization of this conference is a great challenge that we are going to conduct in
close collaboration with our colleagues involved in the so exciting field of the paediatric
dermatology.
Our wish, for this conference, is to offer a scientific programme covering all topics of
our specialty, at the highest level. All day, from 8:00 to 6:00 p.m., many enthusiastic
and highly qualified specialists will propose to share with you their experience and
knowledge. We especially hope that the Congress will be a true moment of encounter
and exchange between dermatologists, paediatricians, researchers and paramedics
involved so deeply to give the best to our young patients and their families.
The scientific programme will highlight all the basic and clinical research advances in
paediatric dermatology, keeping foremost in mind their practical usefulness for patients
and their families. A time for reflection will be organized to try to reinforce European
networks in different areas.
Our specialty is extremely rich, diverse and stimulating. It is this wealth that we want
to live in this conference and, with at the same time, many, human, multi-cultural
encounters.
“Let those who want to turn their backs on the world! I can understand only in human
terms”!*
The conference takes place at the «House of Mutuality» in the centre of old Paris!
Social programmes will be designed to allow discovery of all that is the soul of Paris:
its monuments, museums, history, music, beautiful places and «petits cafés».
We will all be available to help you make the right choices and to enjoy Paris in this
so good time of year in our capital.
We are looking forward to welcoming you in May 2016 to the 13th ESPD Congress!
With best Wishes
Professor Christine Bodemer
Congress President
*“Laissez donc ceux qui veulent tourner le dos au monde.
Je ne puis comprendre qu’en termes humains”,
d’après Albert Camus (L’envers et l’Endroit; Le mythe de Sisyphe)
4
WELCOME FROM THE ESPD PRESIDENT
Dear Friends and Colleagues,
It is with great pleasure that I welcome you to the 13th Congress of the
European Society for Pediatric Dermatology (ESPD) to be held in Paris, from
May 26 to 28, 2016. The French Society for Pediatric Dermatology organized
this congress in close collaboration with the ESPD. As the ESPD is devoted
to achieving the highest quality of training and academic interactions, the
scientific programme will include some of the latest developments in clinical
and experimental Pediatric Dermatology.
We are also looking forward to a relaxed social program organized in this magnificent location in
the medieval center of Paris to favor social interaction between the participants. Such networking
opportunities between pediatric dermatologists, pediatricians, dermatologists, basic scientists,
and clinicians are key to promote international exchange and cooperation. We, a society dedicated
to patient care, clinical teaching and scientific knwoledge, are proud to assist this European
collaboration. Together we can provide excellence in patient care through research! So please
contribute to our development, become active in our society and join the ESPD if you are not yet
a member.
The ESPD is pleased to welcome you to this wonderful venue at the Maison de la Mutualité. We
are sure that you will to enjoy three exciting days crammed with the most recent clinic and scientific
information in pediatric dermatology. I personally would like to thank the local organizers, the
administrative team from MCI, the speakers, the new back office in Prague and last but not least
the sponsors, the pharmaceutical companies, and everybody else who has contributed to bring
our 13th ESPD Congress to life.
Preliminary programme
& Call for abstracts
I wish everybody a pleasant and exciting stay in Paris,
Cordially Yours
Prof. Dr. med. Daniel Hohl
President of the ESPD
ABOUT ESPD
The European Society for Pediatric Dermatology
(ESPD) was established already in 1983 and held
its first Congress in 1984 in Munster, Germany,
organized by Rudolf Happle and Heiko Traupe.
Our Society travelled a long journey since and is
now well established, professional, independent
and non-profit scientific society that strives to
promote clinical care, interdisciplinary research,
education and training. It also serves as a
platform favouring international contacts within
Europe and worldwide in the field of Pediatric
Dermatology.
Our aim is thus to promote at best the interests
of the ESPD and to serve the ESPD and its
members at the same time. This year’s already
the 13th ESPD Congress proves the above to be
a correct direction worth maintaining.
Lately, for a more scientific focus of the
ESPD’s activities in the field, the EUROPEDRA (Pediatric Dermatology Research
Alliance on the European level) Initiative has
been established. We are proud to assist this
European collaboration and to boost interactions
necessary for the development of clinical and
scientific quality in the ESPD. Together we
can provide excellence in patient care through
research!
European Society for Pediatric
Dermatology
C-IN, Prague Congress Centre,
PEDIATRIC
DERMATOLOGY
5.
kvetna 65, 140 21
Prague 4,
Czech Republic
E-mail: office@espd.info
Web: www.espd.info
Tel: +420 261 174 318
Fax: +420 261 174 307
PARIS, FRANCE
5
Both sensitive and strong, our skin envelops and protects us.
It resists the drying wind and the burning sun, it repairs our wounds.
It feels our emotions and the benefits of the sun.
It is our greatest ally, the protector of our body.
At Bioderma, skin is our passion, our expertise, our model.
It is by observing skin’s biology and analysing what it naturally does
best, that we found the inspiration to create dermatological skin cares
that restore its natural balance to strengthen it.
THE SKIN ITSELF inspired BIODERMA to find biological solutions
to preserve the health and beauty of our skin.
NAOS - RCS Lyon 817 485 725 - CL-CS (0196-Avril 2016)
In a lasting way.
BIOLOGY AT THE SERVICE OF DERMATOLOGY
Symposium Mustela
Friday 27th of May 2016
13:00 pm - 14:00 pm
Sorbonne room
Baby’s skin from the
very first days:
equal chances?
Professor Christine Bodemer
Chairwoman, President of the congress
Professor Smail Hadj Rabia, France
Professor Joachim W. Fluhr, Germany
Professor Antonio Torrelo, Spain
Doctor Clarence de Belilovsky, France
• Focus on premature skin
• Skin physiology after birth
new data, different skin types
• Neonatal skincares
a multidisciplinary approach
A lunchbox will be provided at the
entrance of the room.
• Atopic dermatitis prevention
from birth
review and next steps
MUSTELA ® , IT ALL STARTS WITH SKIN
COMMITTEES
STEERING COMMITTEE
Prof Christine BODEMER, Paris
President
Prof Franck BORALEVI, Bordeaux
Vice-President Honorary Presidents
Prof Yves de PROST, Paris
Prof Gérard LORETTE, Tours
Prof Jean-François STALDER, Nantes
Prof Alain TAIEB, Bordeaux
Prof Jean-Philippe LACOUR, Nice
Organising Committee Chairman
Prof Pierre VABRES, Dijon
Scientific Committee Chairman
Prof Smail HADJ-RABIA, Paris
CME/Training Committee Chairman NATIONAL
ORGANISING COMMITTEE
NATIONAL
SCIENTIFIC COMMITTEE
Jean-Philippe LACOUR, Nice
Sébastien BARBAROT, Nantes
Olivia BOCCARA, Paris
Christine BODEMER, Paris
Franck BORALEVI, Bordeaux
Christine LABRÈZE, Bordeaux
Gérard LORETTE, Tours
Emmanuel MAHÉ, Argenteuil
Juliette MAZEREEUW-HAUTIER, Toulouse
Pierre VABRES, Dijon
Brigitte BADER-MEUNIER, Paris
Christine BODEMER, Paris
Franck BORALEVI, Bordeaux
Yves de PROST, Paris
Sylvie FRAITAG, Paris
Smail HADJ-RABIA, Paris
Ludovic MARTIN, Angers
Annabel MARUANI, Tours
8
INTERNATIONAL
SCIENTIFIC COMMITTEE
David ATHERTON, United Kingdom
Ulrike BLUME-PEYTAVI, Germany
Christine BODEMER, France
Ernesto BONIFAZI, Italy
Stéphanie CHRISTEN-ZAECH, Switzerland
Linda DE RAEVE, Belgium
Flora DE WAARD-VAN DER SPEK, The Netherlands
Juan FERRANDO, Spain
Regina FÖLSTER-HOLST, Germany
Carlo GELMETTI, Italy
Ramon GRIMALT, Spain
Rudolf HAPPLE, Germany
John HARPER, United Kingdom
Daniel HOHL, Switzerland
Jan IZAKOVIC, Switzerland
Talia KAKOUROU, Greece
Veronica KINSLER, United Kingdom
Osman KÖSE, Turkey
Barbara KUNZ, Germany
Marc LACOUR, Switzerland
Klara MARTINASKOVA, Slovak Republic
Alberto Joaquim Vieira MOTA, Portugal
Slobodna MURAT-SUSIC, Croatia
Milos NIKOLIC, Serbia
Arnold ORANJE, The Netherlands
J. Henk SILLEVIS SMITT, The Netherlands
Zsuzsanna SZALAI, Hungary
Alain TAIEB, France
Antonio TORRELO, Spain
Umit UKSAL, Turkey
Dirk VAN GYSEL, Belgium
Ayse Deniz YÜCELTEN, Turkey
NATIONAL CME/TRAINING COMMITTEE
Smail HADJ-RABIA, Paris
Emmanuelle BOURRAT, Paris
Frédéric CAMBAZARD, St Etienne
Christine CHIAVERINI, Nice
Hélène DUFRESNE, Paris
Maryam PIRAM, Paris
Jean-François STALDER, Nantes
Alain TAIEB, Bordeaux
9
SCHEDULE AT A GLANCE
WEDNESDAY, 25TH MAY 2016
16:00
19:00
19:00
21:00
REGISTRATION DESK OPENING
GROUND FLOOR
BOARD MEETING ESPD
ROOM: BIÈVRE LEVEL 5
Opening Networking
Amphitheater LEVEL -1 & Exhibition Area LEVEL 3
THURSDAY, 26TH MAY 2016
HOURS
08:00
09:30
09:30
10:00
10:00
11:30
AMPHITHEATER
LEVEL -1
SAINT VICTOR
LEVEL 3
FREE COMMUNICATIONS 1:
DEBATE AND COMMENTS
WITH THE EXPERT CHAIRS
SEMINAR 1:
NEONATAL DERMATOLOGY
SEMINAR 3:
HAIR/SCALP AND NAIL
SYMPOSIUM 1:
ATOPIC DERMATITIS 1
PLENARY LECTURE:
INHERID SKIN DISEASES:
DISCOVERY AND RECOVERY
12:15
13:00
LUNCH BREAK
Poster viewing
& visit of the Exhibition
14:00
14:15
14:15
15:45
12:30 - 13:30
DISCUSSION OF BEST
POSTERS
POSTER AREA
SYMPOSIUM 2:
GENETICS IN PAEDIATRIC
DERMATOLOGY
15:45
16:15
16:15
17:45
10
SEMINAR 2:
ADVANCES IN
DIAGNOSTIC
TECHNIQUES
COFFEE BREAK
Poster viewing & visit of the Exhibition
History of Pediatric Dermatology
11:45
12:15
13:00
14:00
SORBONNE
LEVEL 5
SEMINAR 4:
CONNECTIVE TISSUE
DISEASES: UPDATE
GENERAL
ASSEMBLY ESPD
SATELLITE SYMPOSIUM
PAMPERS
SEMINAR 6:
CHILDHOOD PSORIASIS
SEMINAR 5:
DRUG REACTIONS
AND ALLERGY
COFFEE BREAK
SYMPOSIUM 3:
INFECTIOUS DISEASES
SEMINAR 8:
ACNE AND FACIAL
DERMATOSES
SEMINAR 7:
ICHTHYOSES: UPDATE
LEGEND
Simultaneous translation
from English into French
Limited to 120 seats
FRIDAY, 27TH MAY 2016
HOURS
08:00
09:30
AMPHITHEATER
LEVEL -1
11:45
12:15
12:30 - 13:30
POSTER AREA
DISCUSSION
OF BEST
POSTERS
16:15
18:15
20:00
SEMINAR 9:
MICROSCOPY
SHEDDING LIGHT
ON CLINICS 1
SEMINAR 11:
UV SENSITIVITY
WORKSHOP
PLENARY LECTURE:
PHARMACOGENOMICS
13:00
14:00
15:45
16:15
SEMINAR 12:
ATOPIC DERMATITIS 2
SYMPOSIUM 4:
VASCULAR ANOMALIES
BREAK
Poster viewing
& visit of the
Exhibition
14:15
15:45
SORBONNE
LEVEL 5
COFFEE BREAK
12:15
13:00
14:00
14:15
DEBATE AND COMMENTS
SEMINAR 10 :
NEVI AND NEVOID
OVERGROWTH
09:30
10:00
10:00
11:30
SAINT VICTOR
LEVEL 3
PIERRE FABRE
DERMATOLOGIE
11:45 - 12:45
SATELLITE
SYMPOSIUM
PIERRE FABRE
DERMATOLOGIE
SYMPOSIUM 5:
PIGMENTATION DISORDERS
SATELLITE
SYMPOSIUM
LABORATOIRES
DERMATOLOGIQUES
D’URIAGE
SEMINAR 14:
INFECTIOUS
DISEASES 2
SATELLITE
SYMPOSIUM
LABORATOIRES
EXPANSCIENCE
SEMINAR 13:
CELL
PROLIFERATION
COFFEE BREAK
SYMPOSIUM 6:
UPDATE IN THERAPEUTICS
SEMINAR 15:
AUTO-IMMUNE AND AUTOINFLAMMATORY DISEASES
CONGRESS DINNER
MUSÉE DES ARTS FORAINS PAVILLONS DE BERCY
11
SCHEDULE AT A GLANCE
LEGEND
Simultaneous translation
from English into French
SATURDAY, 28TH MAY 2016
HOURS
AMPHITHEATER
LEVEL -1
08:00
09:30
SEMINAR 17:
BULLOUS AND MUCOUS
MEMBRANE DISORDERS
09:30
10:00
10:00
11:30
12:30
13:00
13:00
13:30
12
DEBATE AND COMMENTS
SORBONNE
LEVEL 5
SEMINAR 16:
ENDOCRINE APPROACH
TO SKIN DISEASES
COFFEE BREAK
SYMPOSIUM 7:
CHANGING PARADIGMS
11:30
12:00
12:00
12:30
SAINT VICTOR
LEVEL 3
PLENARY LECTURE:
THE HUMAN GENETIC
DETERMINISM OF
PEDIATRIC INFECTIOUS
DISEASES
PLENARY LECTURE:
FROM DATA TO
KNOWLEDGE: BIOMEDICAL
DATA WAREHOUSE AND
DATA MINING
CONGRESS CLOSING
SEMINAR 18:
ECTODERMAL DYSPLASIA
SEMINAR 19:
MICROSCOPY
SHEDDING LIGHT
ON CLINICS 2
DETAILED PROGRAMME
16:00
REGISTRATION DESK OPENING
16:00
BOARD MEETING
ROOM: BIÈVRE LEVEL 5
19:00-19:30
OPENING SPEECH
AMPHITHEATER LEVEL -1
Prof. Christine Bodemer, President of the ESPD 2016 congress
Prof. Daniel Hohl, President of the ESPD
19:30-20:00
LES DÉSAXÉS - SAXOPHONE CONCERT
«Les Désaxés», something like the «misfits»
in English, with a SAX in it, as a nod in the
direction of the instrument they play.
First of all, this band of scatty musicians is an
unquestionably sax quartet virtuosi. Prompted
by their passion for entertainment and
challenges they also became actors, dancers,
sounds effect engineers, quite in the same style
as the Marx Brothers.
These artists travelled to every corners of the
world, getting as much distinction as applauses
for their performance.
20:00-21:00
WINE & CHEESE COCKTAIL
IN THE EXHIBITION LEVEL 3
13
08:00-09:30
FREE COMMUNICATIONS 1: Debate and comments with the Expert Chairs SAINT VICTOR LEVEL 3
Chairs: Sebastien Barbarot (Nantes, France), Daniel Hohl (Lausanne, Switzerland)
08:00 | CO01 | Topical corticosteroid phobia in atopic dermatitis: an international validation study
of the topicop score
Stalder J.-F.*, Aubert H., Anthoine E., Moret L., Barbarot S. et Topicop Investigative Group (Nantes, France)
08:09 | CO02 | Monitoring of topical corticosteroid phobia among parents in atopic dermatitis children
with TOPICOP® scale: prevalence, risk factors and therapeutic patient education’s impact
Lasek A.*, Gonzales F., Modiano P. (Lille, France)
08:18 | CO03 | Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review
and meta-analysis
Totté J.*, van der Feltz W., Hennekam M., van Belkum A., van Zuuren E., Pasmans S. (Rotterdam, Netherlands)
08:27 | CO04 | Two Phase 3 studies in atopic dermatitis with crisaborole, the novel, nonsteroidal topical
phosphodiesterase 4 inhibitor
Paller A., Tom W., Lebwohl M., Blumenthal R., Boguniewicz M., Call R., Eichenfield L.*, Forsha D., Rees W.,
Simpson E., Stein Gold L., Zaenglein A., Spellman M., Zane L., Hebert A. (San Diego, United States)
08:36 | CO05 | Superfine merino wool in the management of childhood atopic dermatitis
Su J. C.*, Dailey R., Zallmann M., Leins E., Taresch L., Heah S. S., Donath S., Lowe A. J. (Parkville Melbourne,
Australia)
08:45 | CO06 | Preliminary results of the CLOTHES Trial: a randomised controlled trial of silk clothing for the
management of eczema in children
Thomas K., Burrows N.* et CLOTHES Trial Working Group (Cambridge, United Kingdom)
08:54 | CO07 | Use of systemic agents in pediatric psoriasis: characteristics, comorbidities, and reported adverse
events in an international registry.
Bronckers I.*, Paller A., Kiguradze T., West D., Groenewoud H., Seyger M. et European Working Group on Pediatric
Psoriasis (EWPP) and Pediatric Dermatology Research Alliance (PeDRA) (Nijmegen, Netherlands)
09:03 | CO08 | Obesity and pediatric psoriasis: Prevalence, impact on disease severity and progression
Ergun T., Seckin Gencosmanoglu D., Aydiner E., Salman A., Tekin B.*, Bulbul-Baskan E., Alpsoy E., Cakiroglu A.,
Onsun Onarir N. (Istanbul, Turkey)
09:12 | CO09 | Management of childhood psoriasis in France. A national survey among general practitioners,
pediatricians, and dermatologists
Mahé E.*, Bursztejn A.-C., Phan A., Corgibet F., Sid-Mohand D., Beauchet A., Sigal M.-L. (Argenteuil, France)
09:21 | CO10 | Safe and Effective Use of Photo(chemo)therapy in Children: A Single-Center Retrospective Review
Tekin B.*, Seckin Gencosmanoglu D., Yucelten D., Ergun T. (Istanbul, Turkey)
08:00-09:30
SEMINAR 1: NEONATAL DERMATOLOGY
Expert Chairs: Talia Kakourou (Athens, Greece), Arnold Oranje (Rotterdam, The Netherlands)
•
•
•
08:00-09:30
Exanthema in neonates Peter Hoeger (Hamburg, Germany)
Iatrogenic disorder Mario Cutrone (Venice, Italy)
Congenital skin defects Smail Hadj-Rabia (Paris, France)
SEMINAR 2: ADVANCES IN DIAGNOSTIC TECHNIQUES
SORBONNE LEVEL 5
Expert Chairs : Pierre Vabres (Dijon, France), Susanna Puig (Barcelona, Spain)
•
•
•
14
Dermoscopy and confocal imaging in childhood, Susana Puig (Barcelona, Spain)
Imaging in vascular anomalies and prenatal diagnosis, Audrey Lacalm (Lyon, France)
Advances in molecular diagnosis, Jean-Baptiste Rivière (Montreal, Canada)
09:30-10:00
COFFEE BREAK - POSTER VIEWING LEVEL 5 & VISIT OF THE EXHIBITION LEVEL 3
09:30-10:00 History of Pediatric Dermatology
Speaker: Alain Taieb (Bordeaux, France)
10:00-11:30 SYMPOSIUM 1: ATOPIC DERMATITIS 1 AMPHITHEATER LEVEL -1
Expert Chairs: Marjolein de Bruin-Weller (Utrecht, The Netherlands), Alain Taieb (Bordeaux, France)
•
•
•
10:00-11:30 Epidemiology and co-morbidities, Carsten Flohr (London, United Kingdom)
Epidermal Barrier and genetics, Alan Irvine (Dublin, Ireland)
Targeted therapeutic strategies, Andreas Wollenberg (Munich, Germany)
SEMINAR 3: HAIR/SCALP AND NAIL
SAINT VICTOR LEVEL 3
Expert Chairs: Robert Baran (Cannes, France), Annalisa Patrizi (Bologna, Italy)
SOLVING CLINICAL SITUATION THROUGH ADVANCES IN KNOWLEDGE
•
•
•
10:00-11:30 Diagnosis of nail disorders in children, Bertrand Richert (Brussels, Belgium)
Alopecia areata, Ramon Grimalt (Barcelona, Spain)
Nodular lesions of the scalp, Hala Megarbané (Beirut, Lebanon)
SEMINAR 4: CONNECTIVE TISSUE DISEASES: UPDATE
SORBONNE LEVEL 5
•
•
•
11:45-12:15 Pseudoxanthoma Elasticum, Ludovic Martin (Angers, France) Cutis Laxa, Eli Sprecher (Tel Aviv, Israel) Hereditary Connective Tissue Diseases in Young Adult Stroke
Olivier Vanakker (Gent, Belgium)
PLENARY LECTURE
INHERITED SKIN DISEASES: DISCOVERY AND RECOVERY
Speaker: John McGrath (London, United Kingdom) 12:15-14:15 BREAK - POSTER VIEWING LEVEL 5 & VISIT OF THE EXHIBITION LEVEL 3
12:30-13:00 GENERAL ASSEMBLY ESPD
SORBONNE - LEVEL 5
12:30-13:30 DISCUSSION OF BEST POSTERS - POSTER AREA - LEVEL 5
13:00-14:00 SATELLITE SYMPOSIUM PAMPERS
EVIDENCE-BASED CARE PRACTICES AND GUIDELINES ON INFANT SKIN CARE
Expert Chairs: Olivier Vanakker (Gent, Belgium), Anca Chiriac (Lasi, Romania) Chair: Alain Taieb (Bordeaux, France)
•
•
•
Skin characteristics of the newborn Dirk Van Gysel (Aalst, Belgium)
Skin care in newborn infants - Latest update
Ioanna Thanopoulou (Athens, Greece)
Skin care in children with barrier dysfunction Barbara Kunz (Hamburg, Germany)
15
14:15-15:45 SYMPOSIUM 2: GENETICS IN PAEDIATRIC DERMATOLOGY
Expert Chairs: John McGrath (London, United Kingdom), Elie Sprecher (Tel Aviv, Israel) •
•
•
14:15-15:45 Genetics of vascular anomalies, Miikka Vikkula (Brussels, Belgium)
Gene therapy of Skin disorders, Alain Hovnanian (Paris, France)
Revertant mosaicism: therapeutic perspectives, Marcel Jonkman (Groningen, The Netherlands)
SEMINAR 5: DRUG REACTIONS AND ALLERGY SORBONNE LEVEL 5
Expert Chairs: Petra Staubach (Mainz, Germany), Annick Barbaud (Nancy, France)
• Drug reaction assessment : state of the art, Annick Barbaud (Nancy, France)
• Urticaria, Martin Church (Berlin, Germany)
• Contact dermatitis in children, Dominique Tennstedt (Leuven, Belgium)
14:15-15:45 SEMINAR 6: CHILDHOOD PSORIASIS
Expert Chairs: John Harper (London, United Kingdom), Lawrence Eichenfield
(San Diego, United States) •
•
•
Epidemiology-Comorbidities, Emmanuel Mahé (Argenteuil, France)
Treatment, Marieke Seyger (Nijmegen, The Netherlands)
Particularities of psoriasis in infants and preschool children, Danielle Marcoux, (Montreal, Canada)
15:45-16:15 COFFEE BREAK - POSTER VIEWING LEVEL 5 & VISIT OF THE EXHIBITION LEVEL 3
16:15-17:45 SYMPOSIUM 3: INFECTIOUS DISEASES
Expert Chairs: Emmanuel Laffitte (Geneva, Switzerland), Regina Fölster-Holst (Kiel, Germany)
•
•
•
16:15-17:45 Scabies, Franck Boralevi (Bordeaux, France) Bacterial Toxin Disorders, Annalisa Patrizi (Bologna, Italy)
Infectious diseases in Immune Deficiencies: Focus on new data? Emmanuelle Jouanguy (Paris, France) SEMINAR 7: ICHTHYOSES: UPDATE
SORBONNE LEVEL 5
Expert Chairs: Heiko Traupe (Munster, Germany), Juliette Mazereeuw-Hautier (Toulouse, France)
•
•
•
16:15-17:45 Genetics and classification, Judith Fischer (Freiburg, Germany) What can we expect from a skin biopsy, Stéphanie Leclerc-Mercier (Paris, France)
General rules of management, Angela Hernandez (Madrid, Spain)
SEMINAR 8: ACNE AND FACIAL DERMATOSES
Expert Chairs: Zsuzsanna Szalai (Budapest, Hungary), Nadia Ismaili (Rabat, Morocco) SOLVING CLINICAL SITUATION THROUGH ADVANCES IN KNOWLEDGE Adolescent acne, Christos Zouboulis (Berlin, Germany)
Diagnostic approach to facial rash, Carlo Gelmetti (Milan, Italy) Rosacea and aseptic facial granuloma, Olivia Boccara (Paris, France)
•
•
•
16
08:00-09:30
FREE COMMUNICATIONS 2: Debate and comments with the Expert Chairs
Chairs: Ludovic Martin (Angers, France), Anette Bygum (Odense, Denmark)
08:00 | CO11 | Skin patterns associated with upper airway infantile hemangiomas: a retrospective multicenter study.
Uthurriague C.*, Boccara O., Catteau B., Fayoux P., Léauté-Labrèze C., Chiaverini C., Maruani A., PondavenLetourmy S., Alaidarous K., Puzenat E., Hubiche T., Mallet S., Dreyfus I., Mazereeuw-Hautier J. (Toulouse, France)
08:09 | CO12 | Multiple infantile haemangiomas–who to screen for extra-cutaneous complications?
Mahon C.*, Alband N., Kinsler V. (London, United Kingdom)
08:18 | CO13 | Hypothyroidism in the early phase of infantile hemangiomas.
Bonniaud B.*, Triquet G., Nardin C., Perez-Martin S., Ben Signor C., Vabres P. (DIJON, France)
08:27 | CO14 | Radiological Investigations of midline infantile haemangiomas overlying the scalp or spine:
5 year single centre experience
Cartledge N.*, Kinsler V., Martinez A. (London, United Kingdom)
08:36 | CO15 | LYMPHATIC NET-LIKE MALFORMATION
Noguera-Morel L.*, Stein S., Xirotagaros G., Hernández-Martín Á., De Prada I., Requena L., Frieden I., Torrelo A.
(Madrid, Spain)
08:45 | CO16 | Topical sirolimus for facial angiofibromas
Carvalho S.*, Machado S., Mota F., Selores M. (Oporto, Portugal)
08:54 | CO17 | Distribution of bradykinin-mediated angio-oedema conditions in paediatric patients admitted
to a reference centre
Sarre M.-E., Humeau H., Troussier F., Chapotte C., Ponard D., Drouet C., Martin L.* (ANGERS, France)
09:03 | CO18 | Dermatological features of Kawasaki disease: data extracted from the French Kawasaki disease
cohort (Kawanet)
Specht C.*, Darce M., Brochard K., Lechevalier P., Launay E., Kone Paut I., Piram M. et the Kawanet study group
(Le Kremlin-Bicêtre, France)
09:12 | CO19 | Sun exposure in school: evaluation of risk (erythemal dose), profit (vitamien D synthesis), and
behaviors, in France
Mahé E.*, de Paula Correa M., Vouldoukis I., Godin-Beekmann S., Beauchet A. (Argenteuil, France)
09:21 | CO20 | Retrospective study of ivermectin treatment in 12 patients with rosacea and / or perioral dermatitis
Noguera-Morel L.*, Gerlero P., Hernández-Martín Á., Torrelo A. (Madrid, Spain)
08:00-09:30 SEMINAR 9: MICROSCOPY SHEDDING LIGHT ON CLINICS 1
SORBONNE LEVEL 5
Expert Chairs: David Atherton (London, United Kingdom), Bernard Cribier (Strasbourg, France)
•
•
•
•
08:00-09:30
Genodermatoses - Pathology, Stéphanie Leclerc-Mercier (Paris, France)
Genodermatoses - Clinics, Daniel Hohl (Lausanne, Switzerland)
Tumours - Pathology, Sylvie Fraitag (Paris, France) Tumours, Lisa Weibel (Zürich, Switzerland)
SEMINAR 10: NEVI AND NEVOID OVERGROWTH
Expert Chairs: Rudolf Happle (Freiburg, Germany), Peter Steijlen (Maastricht, The Netherlands)
•
•
•
09:30-10:00 Congenital melanocytic nevi, Veronica Kinsler (London, United Kingdom)
Cloves and overgrowth sydromes, Pierre Vabres (Dijon, France)
Epidermal nevi, Antonio Torrelo (Madrid, Spain) COFFEE BREAK - POSTER VIEWING LEVEL 5
& VISIT OF THE EXHIBITION LEVEL 3
17
10:00-11:30 SYMPOSIUM 4: VASCULAR ANOMALIES
Expert Chairs: Aïcha Salhi (Algiers, Algeria), Jean-Philippe Lacour (Nice, France) •
•
•
10:00-11:30 Congenital vascular tumours, Peter Hoeger (Hamburg, Germany)
Drug therapy of va in 2016, Christine Labreze (Bordeaux, France) Port wine stains : lasers and beyond, Eulalia Baselga (Barcelona, Spain)
SEMINAR 11: UV SENSITIVITY
SORBONNE LEVEL 5
Expert Chair: Emmanuel Mahé (Paris, France), Jan Izakovic (Basel, Switzerland) •
•
•
10:00-11:30 SPONSORED BY
SEMINAR 12: ATOPIC DERMATITIS 2
Expert Chairs: Jean-François Stalder (Nantes, France), Peter Schmid-Grendelmeier
(Zurich, Switzerland) •
•
•
11:45-12:15 Porphyrias, Jean-Charles Deybach (Paris, France)
Poikilodermas, Leena Bruckner Tuderman (Freiburg, Germany)
UV protection in children, Jan Izakovic (Basel, Switzerland)
Atopic dermatitis, the Skin-Disease, Daniel Wallach (Paris, France)
Update Treatments, Thomas Luger (Münster, Germany) Patient Education, Sebastien Barbarot (Nantes, France)
PLENARY LECTURE
PHARMACOGENOMICS
Speaker: Munir Pirmohamed (Liverpool, United Kingdom)
11:45-12:45 WORKSHOP PIERRE FABRE DERMATOLOGIE
MOLLUSCUM CONTAGIOSUM: PATIENT ADAPTED TREATMENT
Chair & Speaker: Antonio Torrelo (Madrid, Spain)
•
•
•
12:15-14:15
Update in the management of Molluscum contagiosum
Clinical Cases
Questions
BREAK - POSTER VIEWING LEVEL 5 & VISIT OF THE EXHIBITION LEVEL 3
12:30-13:30 DISCUSSION OF BEST POSTERS - POSTER AREA - LEVEL 5
13:00-14:00 SATELLITE SYMPOSIUM PIERRE FABRE DERMATOLOGIE
NEW LOOKS ON INFANTILE HEMANGIOMA
• The new face of infantile hemangiomas since the use of propranolol,
•
•
18
Christine Leaute-Labreze (Bordeaux, France) & Alain Delarue (Lavaur, France)
A new look on patients: seeing beyond diagnosis, the Positive Exposure experience
in vascular anomalies, Rick Guidotti (New York City, USA)
Conclusion
13:00-14:00 SATELLITE SYMPOSIUM LABORATOIRES DERMATOLOGIQUES D’URIAGE ATOPIC DERMATITIS : WHAT’S HOT ?
Chair: Yves De Prost (Paris, France)
•
•
•
13:00-14:00 Microbioma, innate immunity and antimicrobial peptides in AD.
Carlo Gelmetti (Milano, Italie)
New therapies in AD. Jean-Philippe Lacour (Nice, France)
Lipoxins and Toll Like Receptors as targets of maintenance therapy.
Marius-Anton Ionescu (Paris, France)
SATELLITE SYMPOSIUM LABORATOIRES EXPANSCIENCE
BABY’S SKIN FROM THE VERY FIRST DAY: EQUAL CHANCES?
SORBONNE LEVEL 5
Chair: Christine Bodemer (Paris, France)
•
•
•
•
14:15-15:45 Focus on premature skin Smail Hadj Rabia (Paris, France)
Skin physiology after birth: New data, different skin types? Joachim Fluhr (Berlin, Germany)
Neonatal skin cares: a multidisciplinary approach Clarence de Belilovsky (Paris, France)
Atopic dermatitis prevention from birth: review and next steps
Antonio Torrelo (Madrid, Spain) SYMPOSIUM 5: PIGMENTATION DISORDERS
Expert Chairs: J. Henk Sillevis Smitt (Amsterdam, The Netherlands), Thierry Passeron (Nice, France)
•
•
•
14:15 - 15:45
Congenital melanocytic nevi management, Suzanne Pasmans (Rotterdam, The Netherlands)
Vitiligo, Khaled Ezzedine (Paris, France)
Pigmentation in RASopathies, Veronica Kinsler (London, United Kingdom)
SEMINAR 13: CELL PROLIFERATION
SORBONNE LEVEL 5
SOLVING CLINICAL SITUATION THROUGH ADVANCES IN KNOWLEDGE Mastocytosis, Dirk Van Gysel (Aalst, Belgium)
Cutaneous pediatric lymphoproliferative disorders, Lorenzo Cerroni (Graz, Austria)
Spitz Tumours and Pediatric melanoma, Arnaud de la Fouchardière (Lyon, France)
•
•
•
14:15 - 15:45
SEMINAR 14: INFECTIOUS DISEASES 2
Expert Chairs: Danielle Marcoux, (Montreal, Canada), Frederic Cambazard (Saint Etienne, France)
Herpesviruses, Marie-Anne Morren (Leuven, Belgium)
Tinea and onychomycosis, Arti Nanda (Salmiya, Kuwait)
Viral Exanthem, Regina Fölster-Holst (Kiel, Germany) •
•
•
15:45-16:15 COFFE BREAK - POSTER VIEWING LEVEL 5 & VISIT OF THE EXHIBITION LEVEL 3
16:15-17:45 SYMPOSIUM 6: UPDATE IN THERAPEUTICS
Expert Chairs : Yves de Prost (Paris, France), Linda De Raeve (Brussels, Belgium)
•
•
•
Expert Chairs: Sylvie Fraitag (Paris, France), Eulalia Baselga (Barcelona, Spain)
Antibiotics : use and misuse, Lawrence Eichenfield (San Diego, United States)
Biologics in paediatric dermatology, Catherine McCuaig (Montreal, Canada)
Hot topics in childhood therapeutics, Annabel Maruani (Tours, France)
19
16:15-18:15
SEMINAR 15: AUTO-IMMUNE AND AUTO-INFLAMMATORY DISEASES
Expert Chairs: Antonio Torrelo (Madrid, Spain), Stéphanie Christen-Zaech (Lausanne, Switzerland)
•
•
•
•
20:00
Kawasaki Disease, Maryam Piram (Paris, France)
Granulomatous diseases in children, Carine Wouters (Leuven, Belgium)
Candle syndrome, Antonio Torrelo (Madrid, Spain)
Pediatric Lupus Update, Brigitte Bader-Meunier (Paris, France) CONGRESS DINNER - MUSÉE DES ART FORAINS
08:00-09:30
FREE COMMUNICATIONS 3: Debate and comments with the Expert Chairs
Chairs: Pierre Vabres (Dijon, France), Regina Fölster-Holst (Kiel, Germany)
08:00 | CO21 | Absence of phenotypic predictors of PIK3CA mosaicism in a cohort of children with vascular
malformations with and without overgrowth
Polubothu S.*, Knox R., Al-Olabi L., Eastwood D., Eleftheriou G., Gholam K., Glover M., Kangesu L., Lomas D.,
Mahon C., Martinez A., Shaw L., Sivakumar B., Smith G., Syed S., Tasani M., Parker V., Semple R., Kinsler V.
(London, United Kingdom)
08:09 | CO22 | Postzygotic BRAF p.Lys601Asn Mutation in Phacomatosis Pigmentokeratotica with Woolly Hair
Naevus and Focal Cortical Dysplasia.
Kuentz P., Mignot C., Bonniaud B.*, Duffourd Y., Olivier-Faivre L., Rivière J.-B., Vabres P. (DIJON, France)
08:18 | CO23 | Postzygotic activating mutations of MTOR cause hypomelanosis of Ito with brain overgrowth
Vabres P.*, Parker V., Mignot C., Duffourd Y., Olivier-Faivre L., Semple R., Rivière J.-B. (DIJON, France)
08:27 | CO24 | Phenotypic and genotypic characterisation of extensive dermal melanocytosis
Polubothu S.*, Al-Olabi L., Vabres P., Riviere J.-B., Kinsler V. (London, United Kingdom)
08:36 | CO25 | Combination of palmoplantar keratoderma and hair shaft anomalies: a warning signal of severe
cardiac disorder? A systematic review on desmosomal diseases
Polivka L.*, Bodermer C., Hadj-Rabia S. (Paris, France)
08:45 | CO26 | Inherited Junctional Epidermolysis Bullosa with COL17A1 mutations: genotypic and phenotypic
analysis of 30 cases
Herisse A.-L.*, Chiaverini C., Charlesworth A., Bourrat E., Gaudron S., Meneguzzi G. , Hadj-Rabia S., Bodemer C.,
Lacour J-P. (Nice, France)
08:54 | CO27 | Pain evaluation of patients with localized epidermolysis bullosa simplex
Brun J.*, Chiaverini C., Leclerc-Mercier S., Mazereeuw J., Bourrat E., Lacour J. P. et Research Group of the
French Society of Pediatric Dermatology (Nice, France)
09:03 | CO28 | A 17-year retrospective review of the incidence, diagnosis and outcomes of retinal pathology in
infants with incontinentia pigmenti
Alband N., Mahon C., Glover M., Gholam K., Henderson R., Wong C., Martinez A. E.* (London, United Kingdom)
09:12 | CO29 | Familial BAP1 mutation presenting in a child with innocuous-looking skin lesions demonstrating
histologically distinct subtype of atypical Spitzoid tumour, and fatal paraganglioma in the father
Watchorn R. E.*, Calonje E., Taibjee S. (Exeter, United Kingdom)
09:21 | CO30 | Cutaneous granulomas in patients with Nijmegen Breakage Syndrome (NBS) and Ataxiatelangiectasia (AT) – diagnostic and treatment challenge
Heropolitanska-Pliszka E.*, Pietrucha B., Wolska-Kuśnierz B., Piatosa B. (Warsaw, Poland)
20
08:00-09:30
SEMINAR 16: ENDOCRINE APPROACH TO SKIN DISEASES SORBONNE LEVEL 5
Expert Chairs: Maya El Hachem (Rome, Italy), Anna Belloni Fortina (Padua, Italy)
•
•
•
08:00-09:30
Hormonal assessment in skin diseases, Michel Polak (Paris, France)
HPA axis in topical steroid therapy, Flora de Waard-van der Spek (Rotterdam / Schiedam,
The Netherlands) & Arnold Oranje (Rotterdam / Alkmaar / Breda, The Netherlands)
Hypertrichoses in children, Christine Chiaverini (Nice, France)
SEMINAR 17: BULLOUS AND MUCOUS MEMBRANE DISORDERS AMPHITHEATER LEVEL -1
Expert Chairs: Johann Bauer (Salzburg, Austria), Peter Itin (Basel, Switzerland) •
•
•
Pediatric autoimmune bullous diseases, Emmanuel Laffitte (Geneva, Switzerland) Epidermolysis bullosa, Cristina Has (Freiburg, Germany)
Genital lichen sclerosus, Peter Itin (Basel, Switzerland)
09:30-10:00 COFFE BREAK - POSTER VIEWING LEVEL 5 & VISIT OF THE EXHIBITION LEVEL 3
10:00-11:30
SYMPOSIUM 7: CHANGING PARADIGMS
Expert Chairs: Antonio Torrelo (Madrid, Spain), Leena Bruckner (Freiburg, Germany) •
•
•
10:00 - 11:30
Inflammation to autoinflammation, Christine Bodemer (Paris, France) From nevi to mosaics, Rudolf Happle (Freiburg, Germany) Microbiome, Jean-François Bach (Paris, France)
SEMINAR 18: ECTODERMAL DYSPLASIA
•
•
•
10:00 - 12:00
Pathophysiological pathways, Smaïl Hadj-Rabia (Paris, France) New Ectodermal dysplasias Syndrome, Gianluca Tadini (Milan, Italy)
Genetic approach to hair dysplasia, Regina Betz (Bonn, Germany)
SEMINAR 19: MICROSCOPY SHEDDING LIGHT ON CLINICS 2
SORBONNE LEVEL 5
Expert Chairs: Ernesto Bonifazzi (Bari, Italy), Alice Phan (Lyon, France) •
•
•
•
12:00-12:30
Vascular anomalies - Pathology, Isabel Colmenero (Birmingham, United Kingdom)
Vascular anomalies - Clinics, Peter Hoeger (Hamburg, Germany) Inflammatory diseases - Pathology, Jaime Eduardo Calonje (London, United Kingdom) Inflammatory diseases - Clinics, Maya El Hachem (Rome, Italy)
PLENARY LECTURE AMPHITHEATER LEVEL -1
THE HUMAN GENETIC DETERMINISM OF PEDIATRIC INFECTIOUS DISEASES,
Speaker: Anne Puel (Paris, France)
12:30-13:00
PLENARY LECTURE AMPHITHEATER LEVEL -1
FROM DATA TO KNOWLEDGE: BIOMEDICAL DATA WAREHOUSE AND DATA MINING
Expert Chairs: Celia Moss (Birmingham, United Kingdom), Smaïl Hadj-Rabia (Paris, France)
Speaker: Nicolas Garcelon (Paris, France)
13:00-13:30
CONGRESS CLOSING
21
INDEX OF CHAIRS AND SPEAKERS
A
Atherton David, 17
B
Bach Jean-François, 21
Bader-Meunier Brigitte, 20
Baran Robert, 15
Barbarot Sebastien, 14, 18
Barbaud Annick, 16
Baselga Eulalia, 18, 19
Bauer Johann, 21
Belloni Fortina Anna, 21
Betz Regina, 21
Boccara Olivia, 16
Bodemer Christine, 19, 21
Bonifazi Ernesto, 21
Bonniaud Bertille, 17, 20
Boralevi Franck, 16
Bronckers Inge, 14
Bruckner-Tuderman Leena, 18, 21
Brun Jennifer, 20
Burrows Nigel, 14
Bygum Anette, 17
C
Cambazard Frederic, 19
Cartledge Natalia, 17
Carvalho Sandrina, 17
Cerroni Lorenzo, 19
Chiaverini Christine, 21
Chiriac Anca, 15
Christen-Zaech Stephanie, 20
Church Martin, 16
Colmenero Isabel, 21
Cribier Bernard, 17
Cutrone Mario, 14
D
De Belilovsky Clarence, 19
De Bruin-Weller Marjolein, 15
De la Fouchardière Arnaud, 19
Delarue Alain, 18
Deybach Jean-Charles, 18
De Prost Yves, 19
De Raeve Linda, 19
De Waard-Van Der Spek Flora, 21
E
Eduardo-Calonje Jaime, 21
Eichenfield Lawrence, 14, 16, 19
El Hachem Maya, 21
Ezzedine Khaled, 19
F
Fischer Judith, 16
Flohr Carsten, 15
Fluhr Joachim, 19
Fölster-Holst Regina, 16, 19, 20
Fraitag Sylvie, 17, 19
22
G
Garcelon Nicolas, 21
Gelmetti Carlo, 16, 19
Grimalt Ramon, 15
Guidotti Rick, 18
H
Hadj-Rabia Smaïl, 4, 19, 21
Happle Rudolf, 17, 21
Harper John, 16
Has Cristina, 21
Herisse Anne-Laure, 20
Hernandez Angela, 16
Heropolitanska-Pliszka Edyta, 20
Hoeger Peter, 14, 18, 21
Hohl Daniel, 14, 17
Hovnanian Alain, 16
I
Ionescu Marius-Anton, 19
Irvine Alan, 15
Ismaili Nadia, 16
Itin Peter, 21
Izakovic Jan, 18
J
Jonkman Marcel, 16
Jouanguy Emmanuelle, 16
K
Kakourou Talia, 14
Kinsler Veronica, 17, 19
Kunz Barbara, 15
L
Labreze Christine, 18
Lacalm Audrey, 14
Lacour Jean-Philippe, 18, 19
Laffitte Emmanuel, 16, 21
Lasek Audrey, 14
Leclerc-Mercier Stéphanie, 16, 17
Luger Thomas, 18
M
Mahé Emmanuel, 14, 16, 17, 18
Mahon Caroline, 17
Marcoux Danielle, 16, 19
Martin Ludovic, 15, 17
Martinez Anna E., 20
Maruani Annabel, 19
Mazereeuw-Hautier Juliette, 16
McCuaig Catherine, 19
McGrath John, 15, 16
Megarbané Hala, 15
Morren Marie-Anne, 19
Moss Celia, 21
N
Nanda Arti, 19
Noguera-Morel Lucero, 17
O
Oranje Arnold, 14, 21
P
Pasmans Suzanne, 19
Passeron Thierry, 19
Patrizi Annalisa, 15, 16
Phan Alice, 21
Piram Maryam, 20
Pirmohamed Munir, 18
Polak Michel, 21
Polivka Laura, 20
Polubothu Satyamaanasa, 20
Puel Anne, 21
Puig Susanna, 14
R
Richert Bertrand, 15
Rivière Jean-Baptiste, 14
S
Salhi Aïcha, 18
Sarre Marie-Elodie, 17
Schmid-Grendelmeier Peter, 18
Seyger Marieke, 16
Sillevis Smitt J. Henk, 19
Specht Clémentine, 17
Sprecher Eli, 15, 16
Stalder Jean-François, 14, 18
Staubach Petra, 16
Steijlen Peter, 17
Su John, 14
Szalai Zsuzsanna, 16
T
Tadini Gianluca, 21
Taieb Alain, 15
Tekin Burak, 14
Tennstedt Dominique, 16
Thanopoulou Ioanna, 15
Torrelo Antonio, 17, 18, 19, 20, 21
Totté Joan, 14
Traupe Heiko, 16
U
Uthurriague Claire, 17
V
Vabres Pierre, 14, 17, 20
Van Gysel Dirk, 15, 19
Vanakker Olivier, 15
Vikkula Miikka, 16
W
Wallach Daniel, 18
Watchorn Richard, 20
Weibel Lisa, 17
Wollenberg Andreas, 15
Wouters Carine, 20
Z
Zouboulis Christos, 16
POSTERS
The poster area is situated on the Level 5.
Plan p. 45
SESSION 1 ROOM: CONSEIL
•
•
•
•
•
•
•
•
•
Autoimmune and inflammatory systemic diseases: From P001 to P002 + P116
Blistering disorders: From P003 to P004
Cases in search of a diagnosis or a treatment: From P005 to P006
Genodermatoses: From P007 to P029 + P117
Hair and nail disorders: From P030 to P031
Inborn errors of metabolism and the skin: From P032 to P034
Malformation syndromes and mosaic skin conditions: From P035 to P042
Neonatal and prenatal dermatology : From P043 to P050
Psoriasis and disorders of cornification: From P051 to P054
SESSION 2 ROOM: PONTOISE
•
•
•
•
•
•
•
•
Acne and facial dermatoses: From P055 to P058
Atopic dermatitis: From P059 to P070
Contact dermatitis and allergy: P071
Drug reactions: P072
Exanthemas: P073
Infections and infestations of the skin: From P074 to P083
Photodermatology: P084
Therapeutic Education: P085
SESSION 3 ROOM: POISSY
•
•
•
•
•
Auto-inflammatory diseases: From P086 to P088
Mastocytosis: P090
Pigmentary disorders: From P091 to P092
Tumors and neoplasia: From P093 to P103 + P118
Vascular anomalies: From P104 to P115
The organisers would like to thank Laboratoire BIODERMA for its help with the design and printing
of the posters chosen for the European Society for Pediatric Dermatology congress.
POSTERS will also be displayed on computer screens on site located in a dedicated
E-POSTERS area on Level 5.
Congress participants will be able to view them any time during the entire duration of the meeting.
The best poster will be awarded a prize of 500 euros by the Bioderma
foundation. The winner will be announced during the congress closing,
held on Saturday 28th May, 13:00, Amphitheater (LEVEL -1)
23
POSTER SESSION 1 ROOM: CONSEIL
AUTOIMMUNE AND INFLAMMATORY SYSTEMIC DISEASES
P001 | An exceptional case of association of cutaneous Langerhans cell histiocytosis and coeliac
disease in a child
Monnier J.*, Morand J.-J., Roman C., Oudin C., Macagno N., Hesse S., Gaudy-Marqueste C., Monestier S., Richard M.-A., Grob
J.-J., Mallet S. (Marseille, France)
P002 | Severe aplastic anemia associated with eosinophilic fasciitis : report of pediatric case.
Victoria M.*, Benoit S., Claire O., Vincent B., Catherine C., Claire G., Sylvie H., Caroline G.-M., Nicolas M., Nathalie C., Gerard M.,
Jean-jacques G., Marie-aleth R., Stephanie M. (Marseille, France)
P116 | More than white patches, white halos, white hairs: Vogt-Koyanagi-Harada syndrome
Hamm* H., Reichel A., Meyer-ter-Vehn T., Wobser M., Holl-Wieden A. (Würzburg, Germany)
BLISTERING DISORDERS
P003 | Using negative pressure wound treatment in a neonate with epidermolysis bullosa
Schwieger-Briel A.*, Schlueer A.-B., Schiestl C., Theiler M., Weibel L. (Zurich, Switzerland)
P004 | Kaposi varicelliform eruption in a patient with Dowling-Meara epidermolysis bullosa
Abasq-Thomas C., Huguen J*., Fraitag S., Misery L. (Brest, France)
CASES IN SEARCH OF A DIAGNOSIS OR A TREATMENT
P005 | Thalidomide in pediatric resistant recurrent aphthous stomatitis
Chasseuil E., Aubert H., Tessier M.-H., Tiriau S., Poignant S., Barbarot S.* (Nantes, France)
P006 | Pustular psoriasis and palmoplantar keratoderma (PPK) with features of ectodermal dysplasia
and mutation in the plakin domain of the desmoplakin gene – a new entity or mere coincidence?
Volc-Platzer B., Gruber R., Rainer G.* (Vienna, Austria)
GENODERMATOSES
P007 | Topical sirolimus as an effective treatment for a deep neurofibroma in a patient with
neurofibromatosis type I.
Levy J. M. S., Fiorillo L.* (Edmonton, Canada)
P008 | Natural history of cutaneous changes in pseudoxanthoma elasticum
Navasiolava N., Maréchal-Girault S., Pararajasingam A., Croué A., Leftheriotis G., Martin L.* (Angers, France)
P009 | Skin fragility-woolly hair syndrome
Mestach L.*, Legius E., Goeteyn M., Morren M.-A. (Leuven, Belgium)
P010 | Papillon–Lefèvre syndrome: Case series of 6 patients and identification of a novel mutation
Tekin B.*, Yucelten D., Beleggia F., Sarig O., Sprecher E. (Istanbul, Turkey)
P011 | Ehlers-Danlos arthrochalasic or cardiac type? Case report
Chiriac A. E., Pinteala T., Butnariu L., Chiriac A.* (iasi, Romania)
P012 | Bannayan-Riley-Ruvalcaba syndrome in a child: a disturbing genetic case.
Bernier V.*, Debray F.-G., Pêtre J., Philippet P. (Liège, Belgium)
P013 | Functional analysis of LEMD3 mutation in Buschke-Ollendorff syndrome
Hagiwara C.*, Nakano H., Sawamura D., Korekawa A. (Hirosaki, Japan)
P014 | GAPO syndrome with growth hormone deficiency
Sahel H., Ait Sahnoune G., Otsmane F., BOUADJAR B.* (Alger, Algeria)
P015 | Collodion baby diagnosed with ichthyosis variegata at the age of 3 years
Pallesen K. A. U.*, Hertz J. M., Fischer J., Hotz A., Clemmensen O., Bygum A. (Odense C, Denmark)
24
P016 | Cutaneous Granular Cell Tumor in Noonan syndrome
Zavattaro E.*, Guala A., Selicorni A., Farinelli P., Giacalone A., Colombo E. (Novara, Italy)
P017 | Mosaic neurofibromatosis type 1. unreported findings and systemic anomalies in a series
of 39 children
Vazquez-Osorio I., Duat-Rodriguez A., García-Martínez F.-J., Torrelo A., Noguera-Morel L., Hernandez-Martin A.* (Gijon, Spain)
P018 | Primary erythromelalgia caused by an idenitifable genetic mutation and treated with a targeted
therapy.
Wlodek C.*, Kelly A., Shaw L. (Bristol, United Kingdom)
P019 | Reflectance confocal microscopy as a non-invasive diagnostic tool for nevoid basal cell
carcinoma syndrome management
Oliveira A.*, Mendes-Bastos P., Zalaudek I. (Lisboa, Portugal)
P020 | Hereditary ichthyosis and achieving the oral mucosa, retrospective study of 33 cases
Omar B. S.*, Amina L. (Tlemcen, Algeria)
P021 | Dermatologic examination revealing Carney complex in a 6-year old girl with ischemic
cerebellar stroke
Abasq-Thomas C.*, Acquitter M., Laparra V., Peudenier S., Clauser E., Misery L. (Brest, France)
P022 | Albino day hospital: a multidisciplinary approach helping for diagnosis and management
of the patients
Morice-Picard F.*, Paya C., Lasseaux E., Labrèze C., Dutkiewicz A.-S., Boralevi F., Arveiler B., Taieb A. (Bordeaux, France)
P023 | Compound heterozygous mutations in COL7A1 gene in a girl with unusual phenotype
of Dystrophic Epidermolysis Bullosa
Colmant C.*, Sznajer Y., Baeck M., Kamsteeg E.-J., Spanoudi-Kitrimi I., Tennstedt D., Dekeuleneer V. (Brussels, Belgium)
P024 | Evaluation of learning disabilities in segmental neurofibromatosis
Marmottant-Debled E., Chiaverini C.*, Fossoud C., Passeron T., Barbarot S., Lacour J.-P. (Nice, France)
P025 | Acanthosis nigricans, hyponchondroplasia and FGFR3 mutation: four cases and review
of the literature
Muguet Guenot L., Aubert H.*, Isidor B., Toutain A., Mazereeuw-Hautier J., Collet C., Bourrat E., Barbarot S. (Nantes, France)
P026 | Two cases of extensive postzygotic mosaicism in epidermolytic ichthyosis closely mimicking
a classical form of epidermolytic ichthyosis
Severino M.*, Tournier E., Chassaing N., Jonca N., Mazereuuw-hautier J. (Toulouse, France)
P027 | A Case of H Syndrome Presenting with Histopathological Features of Rosai-Dorfman Disease
Powell J.*, Cohen V., Miedzybrodzki B. (Montreal, Canada)
P028 | Dermoscopy of basal cell carcinoma in patients with xeroderma pigmentosum
Radia C.*, Salim G., FZ M. (Fez, Morocco)
P029 | Pediatric pilomatricomas in Kabuki syndrome
Marcoux D.*, Schreiber A., Coulombe J., Bernier F.-E. (Québec, Canada)
HAIR AND NAIL DISORDERS
P030 | Halo scalp ring in three children
Garritsen F.*, de Graaf M., Toonstra J. (Utrecht, Netherlands)
P031 | Anterior cervical hypertrichosis: Report of 2 cases
Kieselova K.*, Santiago F., Guiote V., Henrique M. (Leiria, Portugal)
P117 | Clinical Features and Treatment Outcome in Nine Patients with Netherton Syndrome
and Influence of Immunoglobulin on Hair Growth
Niculescu* L., Wollenberg A., Thomas P., Schmidt, Renner E.,Wolff H., Notheis G., Braun-Falco M., Oji4 V., Ruzicka T.,
Fischer J., Giehl K. (Munich, Germany)
25
INBORN ERRORS OF METABOLISM AND THE SKIN
P032 | When Deficits Result in Excess: The Irony of Inborn Errors of Metabolism
A 1-year-old female with Maple Syrup Urine Disease presenting with Acrodermatitis Enteropathicalike lesions
Abad R. M. R.*, Lazo-Dizon J. P. (Manila, Philippines)
P033 | Skin rash in a GLUT1 deficient adolescent
Norrenberg S.*, Bonafé L., Hohl D., Christen-Zäch S. (Lausanne, Switzerland)
P034 | Acrodermatitis enteropathica-like syndrome
Kazandjieva J.*, Guleva D., Sonya M., Nikolova A. (Sofia, Bulgaria)
MALFORMATION SYNDROMES AND MOSAIC SKIN CONDITIONS
P035 | Hallermann- Streiff Syndrome: a new case and difficulties in management
Fatma Zohra Z., fatma zohra D., ryma O., sidi dris A., Bakar B.* (ALGIERS, Algeria)
P036 | Mosaic ectodermal dysplasia-skin fragility syndrome: first reported case
Rodriguez Diaz E.*, Vazquez Osorio I., Gonzalez Sabin M., Bueno E., Gonzalvo P., Torrelo A. (Gijon, Spain)
P037 | A patient with trisomy 20 mosaicism presenting as Hypomelanosis of Ito
Coelho de Sousa V.*, Marques I., Cordeiro A. I., Paiva Lopes M. J. (Lisboa, Portugal)
P038 | Somatic HRAS, PIK3CA and FGFR3 gene mutations in keratinocytic epidermal naevi:
a case series.
Denorme P.*, Morren M.-A., Brems H., Spaepen M., Legius E. (Leuven, Belgium)
P039 | Nevus of striated muscle with segmental hypertrophy: presentation of 3 cases
Torrelo A.*, Boente M. D. C., Noguera-Morel L., Hernández-Martín A., Colmenero I., Asial R., Requena L. (Madrid, Spain)
P040 | Goltz syndrome: a new case in a male patient.
Grandpeix Guyodo C.*, Popovic K., Hjartarson H., Darafshian H., Nordgren A., Magnusson I. (Stockholm, Sweden)
P041 | Neonatal cutis laxa in Sotos syndrome
Bou-assi E.*, Bonniaud B., Grimaldi M., Olivier-Faivre L., Vabres P. (DIJON, France)
P042 | Mutational spectrum of PIK3CA in CLOVES and MCAP syndromes
Kuentz P., Duffourd Y., Olivier-Faivre L., Rivière J.-B., Vabres P.* (DIJON, France)
NEONATAL AND PRENATAL DERMATOLOGY
P043 | Iatrogenic skin disorders and related factors in newborn infants
Csoma Z. R.*, Doró P., Meszes A., Ábrahám R., Tálosi G. (Szeged, Hungary)
P044 | Cutaneous lesions in healthy neonates and their relationship with maternal-neonatal factors
Ábrahám R.*, Meszes A., Bakki J., Gyurkovits Z., Orvos H., Csoma Z. R. (Szeged, Hungary)
P045 | Congenital smooth muscle hamartoma mimicking cutis marmorata telangiectatica congenita
Buechner A.*, Theiler M., Weibel L. (Zurich, Switzerland)
P046 | Characterization of dry skin in vitro and in vivo in a pediatric population
Brédif S., Boyer G.*, Bellemère G., Moga A., de Belilovsky C., BAUDOUIN C. (EPERNON, France)
P047 | Eczema bleeding: key sign in the early diagnosis of Glanzmann disease in an infant
Martín-Santiago A.*, Garcia-Recio M., Knöpfel N., Ferrés L., Hervás D., Bauzá A., Galmés B. (PALMA DE MALLORCA, Spain)
P048 | An unconventional rash
Magnano M., Neri I., Loi C., Patrizi A.*, Bergamaschi R., Gennari M. (Bologna, Italy)
P049 | Typical vascular and pigmentary dermoscopic pattern of capillary malformations in CM-AVM
syndrome: report of three cases.
Gandon C., Bonniaud B., Collet E., Dalac S., Jeudy G., Vabres P.* (Dijon, France)
P050 | Mosaic Activating FGFR2 Mutation in Two Foetuses with Exophytic Papillomatous
Pedunculated Sebaceous Naevus.
Kuentz P., Fraitag S., Gonzales M., Dhombres F., Duffourd Y., Olivier-Faivre L., Rivière J.-B., Vabres P.* (DIJON, France)
26
PSORIASIS AND DISORDERS OF CORNIFICATION
P051 | Aquagenic syringeal acrokeratoderma in a 13-year old boy - a case report
Zychowska M., Baran W.* (Wroclaw, Poland)
P052 | A de-novo CARD14 mutation in an infant with severe erythroderma
Schwieger-Briel A.*, Technau K., Fischer J., Has C. (Zurich, Switzerland)
P053 | « Théo et les psorianautes » (Théo and the Psorianautes) a serious game developed
for children with psoriasis
Aubin M., Piérard N., Mahé E.* (Argenteuil, France)
P054 | Psoriasis can it be associated with contact sensitization in childhood?
Korbi M.*, Belhadjali H., Kammoun S., Youssef M., Mohamed M., Akkari H., Soua Y., Henchi M. A., Zili J. (Monastir, Tunisia)
POSTER SESSION 2 ROOM: PONTOISE
ACNE AND FACIAL DERMATOSES
P055 | Lucie Frey syndrome complicating trigemenal nerve zoster in a child: a rare presentation
Ramid H.*, Hali F., Chiheb S. (Casablanca, Morocco)
P056 | OBSERVATIONAL STUDY IN PREADOLESCENTS WITH FACIAL ACNE VULGARIS
Thouvenin M.-D., Saint Aroman M.*, Rossi A. B. (Lavaur, France)
P057 | Follicular keratosis of the chin – familial occurrence and impressive effect of topical treatment
with tacalcitol
Buechner A.*, Theiler M., Weibel L. (Zurich, Switzerland)
P058 | Familial Frey syndrome: is it only of peripheral nerve origin?
Monia Y., Korbi M.*, benchieikh R., Soua Y., Belhadjali H., Zili J. (Monastir, Tunisia)
ATOPIC DERMATITIS
P059 | Dermatologic Manifestations of Hyper IgE syndrome: study of 19 cases
Ramid H.*, Hali F., Khadir K., Chiheb S. (Casablanca, Morocco)
P060 | Evaluation of new therapeutic molecules on infants with moderate atopic dermatitis: effect
on SCORAD and Quality of Life of patients.
Rouaud-Tinguely P., Boudier D.*, Le Guillou M., Bordes S., Closs B. (Saint-Viance, France)
P061 | The Efficacy of Omalizumab in Patients of Childhood Onset Atopic Dermatitis with High
Serum IgE
Kuo K.-L.*, Wang C.-W., Chung W.-H. (Keelung, Taiwan, Province of China)
P062 | Ex vivo evaluation of the effects of niacinamide and phytosterols on epidermal barrier recovery
following damage
Gasparri F.*, Marconi A., Pincelli C. (Casalfiumanese, Italy)
P063 | The significance of a short term structured educational program for parents of children with
atopic dermatitis on the quality of family life
Pustisek N.*, Šitum M., Vurnek Zivkovic Vurnek M. (Zagreb, Croatia)
P064 | Cyclosporin therapy in children with severe atopic dermatitis. efficacy and adverse effects
profile assessment.
Hernandez-Martin A.*, Noguera-Morel L., Torrelo A., Bernardo-Cuesta B., Perez-Martin M.-A., Aparicio-Lopez C., de LucasCollantes C. (Madrid, Spain)
P065 | Association atopic dermatitis and psoriasis in moroccan children
Elfatoiki F. Z.*, fouzia H., khadir K., chiheb S. (casablanca, Morocco)
27
P066 | Molecular and Conventional Investigation of Penton Valentine Leukocidin (PVL) Production
and Biofilm Forming Abilities of Staphylococcus aureus (S. aureus) Strains Isolated From Anterior
Nares of Children with Atopic Dermatitis
Uzunoglu E.*, Ocal D., Koksuz T., Sahin A. M., Avcı E., Dolapci I. (Giresun, Turkey)
P067 | A new marker of atopic dermatitis
Korbi M.*, Belhadjali H., Soua Y., Youssef M., Mohamed M., Henchi M. A., Zili J. (Monastir, Tunisia)
P068 | How patient-reported outcomes can be useful in routine practice in children with atopic
dermatitis?
Barbarot S.*, Aubert H., Stalder J.-F. (Nantes, France)
P069 | Reduced pruritus and signs of atopic dermatitis in phase 3 trials with a nonsteroidal topical
phosphodiesterase inhibitor, crisaborole
Hebert A., Eichenfield L.*, Lebwohl M., Paller A., Simpson E., Tom W., Spellman M., Hughes M., Zane L. (San Diego, United States)
P070 | Long-term safety of crisaborole in children and adults with mild-to-moderate atopic dermatitis
Eichenfield L.*, Call R., Forsha D., Fowler J., Hebert A., Spellman M., Stein Gold L., Van Syoc M., Zane L., Tschen E. (San Diego,
United States)
CONTACT DERMATITIS AND ALLERGY
P071 | Antiseptics contact dermatitis in children: not only chlorhexidine…
Darrigade A.-S., Boralevi F*., Labrèze C., Milpied B. (BORDEAUX, France)
DRUG REACTIONS
P072 | Fixed drug eruption due to an antipyretic drug containing phenobarbital: Interest of patch test!
Korbi M.*, Belhadjali H., Ben Fredj N., Soua Y., Youssef M., Chaabane A., Mohamed M., Aouam K., Zili J. (Monastir, Tunisia)
EXANTHEMAS
P073 | «Red penis» in infants: two unusual clinical cases.
Cutrone M.*, Valerio E., Favot F., Mattei I. (Venice, Italy)
INFECTIONS AND INFESTATIONS OF THE SKIN
P074 | Mucocutaneous leishmaniasis of the child in a refugee camp
El Amraoui M.*, Boui M. (Rabat, Morocco)
P075 | Trends in onychomycosis in the South West of England between 2006-2014.
Wlodek C.*, Trickey A., Johnson E. M. (Bristol, United Kingdom)
P076 | Study of leprosy in chidren
Rao A. G.* (Mahbubnagar, India)
P077 | Coexistence of immunologically divergent types of cutaneous tuberculosis in immunocompetent
children -a study
Rao A. G.* (Mahbubnagar, India)
P078 | Cutaneous and visceral leishmaniasis in pediatric population: retrospective collection of data
on a Hospital
Hernández-Núñez A.*, Freites A., Tardío J., García E., Molina L., Puente de Pablo N., Borbujo J. (Madrid, Spain)
P079 | Novel gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation in
chronic mucocutaneous candidiasis
Knöpfel N.*, Escudero-Góngora M. D. M., Martínez Pomar N., Molina Fuentes Á., Lacruz L., Dueñas J., Martín-Santiago A. (Palma
de Mallorca, Spain)
P080 | Emergence of african species of dermatophytes in tinea capitis: a 16 year experience at a
montreal pediatric hospital
Marcoux D.*, Dang J., Gendron R. (montreal, Canada)
28
P081 | Tinea capitis outbreak among pediatric refugee population, an evolving health care challenge
Mashiah J.*, Kutz A., Benami R., Savion M., Goldberg I., Ganor T., Zidan O., Sprecher E., Harel A. (Tel-Aviv, Israel)
P082 | Topical imiquimod for external anogenital warts in pediatric population: a retrospective study
of 23 cases.
Genix M.*, Maruani A., Chiaverini C., Boralevi F., Miquel J., Mahé E., Kupfer-Bessaguet I., Cochat P., Phan A. (BRON, France)
P083 | Adverse reactions due to BCG vaccine: 11 cases
Sellami K., Amouri M., Mseddi M.*, Guirat R., Aloulou H., Ben Mansour L., Kamoun T., Kmiha S., Hachicha M., Turki H. (Sfax, Tunisia)
PHOTODERMATOLOGY
P084 | ERythropoietic protoporphyria in two brothers
Romero Pérez D.*, González Villanueva I., Encabo Durán B., Hispán Ocete P., Berbegal De Gracia L., De León Marrero F., Betlloch
Mas I. (Alicante, Spain)
THERAPEUTIC EDUCATION
P085 | Pilot feasibility study: children preference in the choice of galenic formulation in atopic
dermatitis: impact on treatment adherence
Kogge A.*, Chavigny J.-M., Aubert H., Barbarot S., stalder J.-F. (Nantes, France)
POSTER SESSION 3 ROOM: POISSY
AUTO-INFLAMMATORY DISEASES
P086 | Pyoderma gangrenosum in a nursling: atypical presentation
Ramid H.*, Hali F., Chiheb S. (Casablanca, Morocco)
P087 | STING - Associated Vasculopathy with Onset in Infancy: detection of a novel germline point
mutation in the TMEM173 gene associated with a mild phenotype.
Van Aerde E.*, Morren M., Van den Oord J., De Haes P., Wouters C., Meyts I., Legius E. (Leuven, Belgium)
P088 | The interest of potassium iodide in auto-inflammatory syndrome
Korbi M.*, Aounallah A., Fetoui Ghariani N., Zeglaoui H., Boussofara L., Mokni S., Saidi W., Denguezli M., Ghariani N., Belaajouza
C., Rafiaa N. (Sousse, Tunisia)
MASTOCYTOSIS
P090 | Topical Pimecrolimus for Pediatric Cutaneous Mastocytosis
Mashiah J.*, Kutz A., Bodemer C., Hadj Rabia S., Goldberg I., Sprecher E., Harel A. (Tel-Aviv, Israel)
PIGMENTARY DISORDERS
P091 | Dermoscopy in Pigmented Purpuric Dermatosis
Oliveira A.* (Alvor - Algarve, Portugal)
P092 | Eruptive Lentigines and Abnormal Skin Fold Pigmentation after Nitrogen Mustard Treatment
for Langerhans Cell Histiocytosis
Bernigaud C.*, Bonniaud B., Briandet C., Grimaldi M., Vabres P. (DIJON, France)
29
TUMORS AND NEOPLASIA
P093 | A child pyoderma gangrenosum revealing systemic anaplastic lymphoma
Ramli I. I.*, rachadi H., amarouch H., benzekri L., senouci K., hassam B., Ismaili N. (Rabat, Morocco)
P094 | Angiolymphoid Hyperplasia with Eosinophilia occurred in infancy
Korekawa A.*, Nakajima K., Nakano H., Sawamura D. (Hirosaki, Japan)
P095 | Infantile myofibromatosis: a case report of a rare condition.
Marques I.*, Coelho de Sousa V., Diamantino F., Cordeiro A. I., Duarte R., Paiva Lopes M. J. (Barreiro, Portugal)
P096 | Lymphomatoid papulosis in children and adolescents: A Systematic Review
Wieser I.*, Wohlmuth C., Nunez C., Duvic M. (Houston, Texas, United States)
P097 | Langerhans cell histiocytosis involving the skin and the thymus: an underestimated association
and its prognostic value
Escudero Góngora M. D. M.*, Knöpfel N., Guibelalde M., Amador E., Saus C., Bauzá A., Martín-Santiago A. (Palma de Mallorca,
Spain)
P098 | Multiple and desmoplastic spitz nevi arising in congenital speckled lentiginous nevus
Valdivielso M.*, Rivera T., Eguren C., Silvente C., Conde E., Martin A., De la Cueva P. (Madrid, Spain)
P099 | A Raccoon Eyes syndrome associated with neuroblastoma in remission
Plaquevent M.*, SAMAIN A., Filhon B., BALGUERIE X., JOLY P. (Rouen, France)
P100 | Spindle cell haemangioma and abnormal skin pigmentation in constitutional mismatch repair
deficiency syndrome.
Dhers M.*, Bonniaud B., Bernigaud C., Aubriot-Lorton M. H., Briandet C., Bottollier-Colomb E., Wassef M., Olivier-Faivre L., Vabres
P. (DIJON, France)
P101 | Granulomatous mycosis fungoides in an adolescent patient –
A rare case and review of the literature
Wieser I.*, Wohlmuth C., Duvic M. (Salzburg, Austria)
P102 | A case of histiocytosis mimicking a diffuse neonatal hemangiomatosis
Belloni Fortina A.*, Fontana E., Salmaso R. (Padova, Italy)
P103 | Sarcoidosis masquering an anaplastic large cell lymphoma in a child.
Marchetti A.*, Balme B., Cochat P., Phan A. (Lyon, France)
P118 | Clinical, Diagnostic and Therapeutic Aspects in Five Children with Disseminated Juvenile
Xanthogranuloma
Roussel* P., Benoit S., Ruzicka T., Rueff F., Niculescu L., Schmidt H., Hamm H., Giehl K. (Munich, Germany)
VASCULAR ANOMALIES
P104 | Capillary malformation-arteriovenous malformation syndrome: are all the cutaneous stains
actually arteriovenous malformations?
Puente-Pablo N.*, Hernández-Núñez A., Echeverría B., Tardío J. C., Freites A. D., Martínez-Morán C., Martínez-Sánchez D.,
Borbujo J. (Fuenlabrada, Spain)
P105 | Educational intervention and teledermatology, two tools for reducing the age of assessment
and treatment of infantile hemangioma
Betlloch I.*, Azaña J.-M., Martínez-Miravete M.-T. (Alicante, Spain)
P106 | Early use of sirolimus therapy for infants and children with problematic Kaposiform
Haemangioendothelioma and tufted angioma.
Tasani M.*, Glover M. (London, United Kingdom)
P107 | Atenolol treatment for severe infantile hemangiomas: a single-centre prospective study
Alexopoulos A.*, Thanopoulou I., Xaidara A., Chrousos G., Kakourou T. (Athens, Greece)
P108 | A kaposiform hemangioendothelioma successfully and safely treated with sirolimus. Should
sirolimus be first-line treatment for this indication?
Wlodek C.*, Ng A., Shaw L. (Bristol, United Kingdom)
30
P109 | Atenonol: an promising alternative therapy to propranolol for the treatment of infantile
haemangioma.
Tasani M.*, Shaw L. (London, United Kingdom)
P110 | Linear facial posrt-wine stain: a blaschkolinear mosaicism?
Dutkiewicz A.-S.*, Ezzedine K., Mazereeuw-Hautier J., Lacour J.-P., Barbarot S., Vabres P., Miquel J., Balguerie X., Martin L.,
Boralevi F., Bessou P., Morice-Picard F., Chateil J.-F., Léauté-Labrèze C. (BORDEAUX, France)
P111 | Haemangioma in an infant whose mother was receiving long-term propranolol treatment
during pregnancy
Mechineaud M.*, Nicaise D., Martin L. (Angers, France)
P112 | Rapidly and partially involutive congenital hemangiomas: a retrospective study of 51 cases
Boccara O.*, Ronjat L., Gurioli C., Hubiche T., Boralevi F., Bodemer C., Léauté-Labrèze C. (Paris, France)
P113 | Validity of centralized photographic assessment of treatment response in infantile hemangioma.
Vabres P.*, Liacu D., Léauté-Labrèze C., Delarue A., Voisard J.-J. (DIJON, France)
P114 | Association of infantile hemangioma location with presentation at birth
Hars B., Bonniaud B.*, Devilliers H., Perez-Martin S., Vabres P. (DIJON, France)
P115 | Multiple segmental congenital hemangiomas
Bursztejn A.-C.*, Goffinet L., Journeau P., Simon E., Mainard L. (Nancy, France)
Xémose
FOR ATOPIC, DRY SKIN
SCORAD : -52%1
SRRC : -52%1
CLQI : -59%2
Chronoxine
Up-regulate lipoxins3,4
TLR2-Régul
Modulate Toll Like Receptor 23
Cérasterol 2F
Repair intercellular cement3
1
Clinical trial in a series of 75 babies and infants (mean age 2 y.o.). Xémose Crème or Xémose Cérat were applied 2X/
day for 30 days. Dermatologist’s assessment - SCORAD: SCORing Atopic Dermatitis - SRRC: Scaling, Roughness,
Redness, Cracks. 2 Children’s Dermatology Life Quality Index (CDLQI) Lewis-Jones MS, and al.Br J Dermatol 1995;
132(6): 942-9. 3 Uriage Satellite Symposium ESPD 2016 “What’s New in atopic Dermatitis?” De Prost Y, Gelmetti C,
Lacour JP, Ionescu MA. 4 Poster 3777 - American Academy of Dermatology Washington DC - 2016
31
EXHIBITION FLOOR PLAN - MAUBERT LEVEL 3
27
03A
04
24
23
05
06
07
08
28
22
20
08A
03
15
02
14
15A
16
17
13
12
18
19
11
09
01
26
PATIENT SUPPORT GROUPS - ODÉON LEVEL 3
A
B
C
D
E
F
32
LIST OF EXHIBITORS
COMPANIES
BOOTH N°
DOODERM
20
DR HOENLE MEDIZINTECHNIK GMBH
8
H & O EQUIPMENTS SA
LA ROCHE POSAY
LABORATOIRE BIODERMA
9
4-5
1-2-3
LABORATOIRE DERMATOLOGIQUE ACM
18
LABORATOIRE SVR
3A
LABORATOIRES DERMATOLOGIQUES D'URIAGE
22
LABORATOIRES DERMATOLOGIQUES EUCERIN
6-7
LABORATOIRES EXPANSCIENCE
LABORATOIRES NOREVA
LABORATOIRES PIERRE FABRE DERMO-COSMETIQUE
LEO PHARMA
MEDITHEQUE BOOKSHOP
PAMPERS - PROCTER & GAMBLE
12 - 17
23
13 - 14 - 15 - 15A - 16
8A
28
11 - 19
TOPICREM
24
VEA
26
WISEPRESS MEDICAL BOOKSHOP
27
PATIENT SUPPORT GROUPS
PATIENT SUPPORT GROUPS
BOOTH N°
GENESPOIR, Association française des albinismes
A
APPF, Association Pemphigus Pemphigoide de France
B
A.N.R., Association Neurofibromatoses et Recklinghausen
C
Association Française du Vitiligo
D
Association NAEVUS 2000 France - Europe
E
A. Genespoir, Association française des albinismes http://genespoir.org/fr
B. Association Pemphigus/pemphigoide de France (APPF) http://pemphigus.asso.fr
C. Neurofibromatose et Recklinghausen www.anrfrance.fr/anr/
D. Association Française du Vitiligo www.afvitiligo.com
E. Association NAEVUS 2000 France - Europe www.naevus2000franceeurope.org
33
COMPANY PROFILES*
DOODERM
BOOTH N°20
Françoise RAVERDY - 59 Avenue de l’Union 59200 Tourcoing - FRANCE
Phone: +33 9 83 03 89 67 Website: www.dooderm.com
Dooderm sells innovative textiles combining the benefits of natural cotton (95%) and silver metal wire (5%) for
sensitized skin. Metallic silver is known for its anti-inflammatory and anti fungal properties. Dooderm products are
recommended for people suffering from eczéma, psoriasis and allergies. DR HOENLE MEDIZINTECHNIK GMBH
BOOTH N°8
Petra KLEINHANS - Dornierstrasse 4 - 82205 - Gilching - GERMANY
Phone: +49 8105 730290 Fax: +49 8105 73029-50 Email: medizin@drhoenle.de
Website: www.drhoenle.de
Since 40 years, the company Dr. Hönle Medizintechnik GmbH has specialized in the development, manufacture,
sales and service of high-quality UV irradiation devices for the treatment of skin conditions as well as of iontophoresis
devices for the treatment of hyperhidrosis.
H & O EQUIPMENTS SA
BOOTH N°9
Maurice SMEETS - 1 Rue des Journaliers - 7822 - Ghislenghien - BELGIUM
Phone: +32 68 26 86 00 Fax: +32 68 552848 Email: marketing@ho-equipments.com
Website: www.ho-equipments.com
The CryoPen offers the solution of an instrument that can help you to treat warts accurately, quickly, effectively and
with no stress. Meet us at booth 9 to guide you towards a professional approach for additional service to your patients.
LA ROCHE POSAY
BOOTH N°4-5
Marion ALVES DE OLIVEIRA - 3 avenue Sainte Anne - 92600 - Asnières sur Seine - FRANCE
Phone: +33 1 46 88 68 00 Email: marion.alvesdeoliveira@loreal.com
Website: www.laroche-posay.fr
LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE, a worldwide leader in cosmetics offers a complete range
of skincare. Products are developed as main or adjunctive treatments, formulated with La Roche-Posay thermal spring
water, rich in anti-free radicals selenium, and benefit from the latest technical innovations.
LABORATOIRE BIODERMA
BOOTH N°1-2-3
Corinne MINMIN - 75, cours Albert Thomas - 69003 - Lyon - FRANCE
Phone: +33 4 72 11 48 00 - Fax: +33 4 78 53 82 54 - Email: c.minmin@bioderma.com
Website: www.bioderma.com
A pioneer since the 1970s, BIODERMA has acquired unique expertise by placing biology at the service of dermatology.
This original scientific approach relies first and foremost on knowledge of the skin and its biological mechanisms to
formulate products directly inspired by them.
LABORATOIRE DERMATOLOGIQUE ACM
BOOTH N°18
Hélène RUELLAND - 17 rue de Neuilly - 92110 - Clichy - FRANCE
Phone: +33 1 47 37 80 79 Fax: +33 1 47 37 90 88 Email: hruelland@labo-acm.com
Website: www.labo-acm.com
For more than 20 years ACM teams have been developing and marketing skin and cosmetic products for medical
prescription. Our expertise in matters affecting the skin, hair and nails and our close collaboration with the world of
dermatology means we provide effective solution to restore the skin.
34
LABORATOIRE SVR
BOOTH N°: 3A
Anne-Claire BERGEROL - 2 rue de lisbonne - 75008 - Paris - FRANCE
Email: anne.claire-bergerol@filorga.com
Website: http://fr.labo-svr.com
SVR Laboratory, a key player in dermo-cosmetics. The know-how of SVR? Providing formulas with high concentrations
of dermatological active ingredients to maximize performance while ensuring high tolerance for the most sensitive
skins. With SVR, dermatology means beauty.
LABORATOIRES DERMATOLOGIQUES D’URIAGE
BOOTH N°: 22
Dragana STIJAKOVIC - 6 boulevard du Parc - 92200 - Neuilly sur Seine - FRANCE
Phone: +33 1 40 88 45 49 Email: dragana.stijakovic@uriage.com
Website: www.uriage.com
Les Laboratoires Dermatologiques d’Uriage® are since 1992 in the core of dermo-cosmetic innovation and continue
to provide to prescribing doctors and to their patients, ranges of perfectly tolerated and effective products in many
indications in dermatology and pediatric dermatology.
LABORATOIRES DERMATOLOGIQUES EUCERIN
BOOTH N°: 6-7
Ariane SANTERRE - 118 avenue de France - 75214 - Paris cedex 13 - FRANCE
Phone: +33 1 70 37 32 00 Fax: +33 1 70 37 32 30 Email: ariane.santerre@beiersdorf.com
Website: www.eucerin.fr
We are skin care:
- Founded in 1882 Hamburg / Germany
- About 16.500 dedicated employees worldwide
- Global presence with more than 150 affiliates
- Leading international brands like EUCERIN, NIVEA, La Prairie
- More than 130 years of experience in research and development of skin care
LABORATOIRES EXPANSCIENCE
BOOTH N°: 12-17
Khadija NIEGER NAJI - 10 avenue de l’arche - 92400 - Courbevoie - FRANCE
Phone: +33 1 43 34 61 35 Email: knaji@expanscience.com
Website: www.expanscience.com/en
Expanscience a French independently-owned pharmaceutical and dermo-cosmetics laboratory generated turnover of
€272.3 million, 51,3% of which was through exports. The company has built up a solid international reputation as an
innovator and as a specialist in skin and the treatment of arthritis.
LABORATOIRES NOREVA
BOOTH N°: 23
Audrey POPOVICI - 5 rue Louis Bleriot Bâtiment 5C - 63017 - Clermont-Ferrand - FRANCE
Phone: +33 4 73 83 80 80 Email: a.popovici@noreva.com
Noreva Laboratory is a a pioneer laboratory in the field of dermatology for over 20 years. It, answers to the expectations
of dermatologists, pharmacists and consumers, by making available a wide range of highly-efficient treatments that are
in line with dermocosmetics innovations.
LABORATOIRES PIERRE FABRE DERMO-COSMETIQUE
BOOTH N°: 13-14-15-15A-16
Pascale BARRE - 182 Vieille route de Toulouse - 81506 - Lavaur - FRANCE
Phone: +33 5 63 58 97 00 Email: pascale.barre@pierre-fabre.com
Website: www.pierre-fabre.com
We design our dermo-cosmetic care to comply with the most stringent performance and safety criteria. Our
dermo-cosmetic products are recommended by professionals who are trained in our ethical approach to beauty.
35
LEO PHARMA
BOOTH N°: 8A
Agathe MAURY-LE-BRETON - Le Val Saint Quentin 2, rue René Caudron - 78960 - Voisins-Le-Bretonneux - FRANCE
Phone: +33 1 30 14 40 00 Fax: +33 1 34 60 47 90 Email: agathe.maury-le-breton@leo-pharma.com
Website: www.leo-pharma.fr
LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries
globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908, the healthcare company
owned by the LEO Foundation is headquartered in Denmark. www.leo-pharma.com
MEDITHEQUE BOOKSHOP
BOOTH N°: 28
Philippe BON - 88 rue des Moines - 75017 - Paris - FRANCE
Phone: +33 6 11 56 53 81 Fax: +33 1 42 28 21 17 Email: meditheque@noos.fr
Website: www.meditheque.com
Medical books and multimedia products in several languages from all leading publishers.
Sales on site or online www.meditheque.com
PAMPERS - PROCTER & GAMBLE
BOOTH N°: 11-19
Ioannis HATZOPOULOS - Sulzbacher Straße 40 - 65824 - Schwalbach a. Ts. - GERMANY
Phone: + 49 6196 89 4418 Fax: + 49 6196 892 4418 Email: hatzopoulos.i@pg.com
Website: www.pg.com
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands,
including Always®, Ariel®, Gillette®, Head & Shoulders®, Lenor®, Oral-B®, Pampers®, Pantene®, and Vicks®. The
P&G community includes operations in approximately 70 countries worldwide.
TOPICREM
BOOTH N°: 24
Laura MARETHEU - 6, avenue de l’Europe - 78401 - Chatou - FRANCE
Phone: +33 1 34 80 41 17 Fax: +33 1 34 80 41 14 Email: laura.maretheu@topicrem.fr
Website: www.topicrem.com
Topicrem is a dermo-cosmetic brand that belongs to a French family-owned pharmaceutical laboratory. Our
dermatological laboratory offers safe formulas for babies, children and adults’ sensitive skin. Our main areas of
expertise cover: Atopic Dermatitis, Damaged skin, Acne, Xerosis.
VEA
BOOTH N°: 26
Jérome GRAPINET - 89 chemin des cigales - 06370 - Mouans Sartoux - FRANCE
Phone: +33 4 89 35 71 47 Fax: +33 4 93 70 48 69 Email: contact@veafrance.com
Website: www.veafrance.com
The brand name VEA was created and developed by notable experience gained over the years, relatively to the activity
of Vitamin E being able to work on sensitive skin or physiologically compromised skin.
WISEPRESS MEDICAL BOOKSHOP
BOOTH N°: 27
Hannah LEACH - 25 High Path - SW19 2JL - London - UNITED KINGDOM
Phone: +44 0 208 715 1812 Email: marketing@wisepress.com
Website: www.wisepress.com
Wisepress, Europe’s leading conference bookseller, has a range of books and journals relevant to the themes of the
meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific
bookshop online with great offers. Follow us on Twitter @WisepressBooks
* List of exhibitors, company details, profiles and floor plan at the date of printing. All company details and profiles included in the Final
Programme were provided by the exhibitors and it is their responsibility to ensure accuracy.
36
SOCIAL NETWORKING PROGRAMME
OPENING NETWORKING
19:00 - 21:00
Maison de la Mutualité
AMPHITHEATER AND EXHIBITION AREA
All participants and exhibitors are welcome to
join this opening networking session to celebrate
the launch of ESPD 2016 and catch up with
colleagues and friends from all over the world!
(See detailled programme on page 13)
Included in the registration fees
CONGRESS DINER
FRIDAY, 27TH MAY 2016 - 20:00
Musée des Arts Forains
PAVILLONS DE BERCY
Since the beginning of time man has been
attracted by the curious, by illusion and by things
that are extraordinary. where can you find in
Paris such magic place to dream and to adopt a
child’s view of the world?
Come to celebrate ESPD 2016 at the MUSEE DES ARTS FORAINS where you will be drawn into
an extraordinary atmosphere, bringing on a feeling of amusement and conviviality. You will enjoy
attractions and rides in perfect working conditions… Let your sensitivity guides you through this
evening of discovery! Price per Person (VAT included): 120€ for delegates, 120€ for additional tickets
No transfer
TOURS & VISITS
Paris is a dynamic and renowned cultural
capital, always at the forefront of trends and
new ideas. But it is also home to tradition and
history. No matter what you are most inclined
toward, you will always find, in the City of Lights,
something exciting to experience and to match
your tastes and expectations!
A hospitality desk will be located
in the Welcome Area during
the event on 26th and 27th May
for any reservations.
37
GENERAL INFORMATION & ACCESS
VISIT PARIS
Paris is a dynamic and renowned cultural capital, always at the forefront of trends and new ideas. But
it is also home to tradition and history. No matter what you are most interested in, you will always find
it in the «City of Light»; something exciting to experience and to match your tastes and expectations!
Your visit will be an excellent opportunity to discover some of the most outstanding artistic and
historic highlights of Paris and its surrounding areas.
ENJOY PARIS !
THE VENUE
MAISON DE LA MUTUALITÉ
Inaugurated in 1931 by the French President Paul Doumer, the Maison de la Mutualité was one of
the emblematic centres of the capital’s social and cultural life. The building is a magnificent example
of Art Deco architecture and was fully renovated in 2011 by Jean-Michel Wilmotte, who restored
the place to its former glory while adding sober, modern touches to the interior design. Today, the
Maison de la Mutualité has once again become a major venue for events on the Left Bank.
LANGUAGE
The official language of the congress is English.
Simultaneous translation from English into French in the Amphitheater.
CLIMATE AND CLOTHING
The month of May is characterized by rising daily high temperatures, with daily highs increasing from
17°C to 21°C over the course of the month.
CURRENCY EXCHANGE
ALL RATES given in the programme are in EUROS: €
38
ELECTRICITY
Electricity used in France is 220 Volts; its frequency
is 50 Hz and the plugs have two male contact
points. Plan to bring a transformer for your electrical
or electronic equipment using different voltage.
EXHIBITION & SPONSORSHIP
For exhibition or sponsorship, you can contact any
time the Congress Office:
exhibition@espd2016.com
INSURANCE & LIABILITY
The Organisers will accept no liability for personal
injuries sustained by or for loss or damage to
property belonging to Congress participants, either
during or as a result of the Congress or during
all events.
Participants are strongly recommended to seek
insurance coverage for health and accident, lost
luggage and trip cancellation.
LUNCHES
Lunches are NOT included in the registration fees
but sandwiches and snacks can be purchased
within the premises of the Maison de la Mutualité
and its surroundings.
TELEPHONES
For international calls to France, dial the international
code followed by 33 and the correspondent’s
number without the “0”.
VISA & PASSPORTS
Every person entering France should be in
possession of a valid passport and/or identification
card. Some countries require a Visa.
Please contact the nearest French Embassy or
Consulate to your home for further information.
ADDRESS
24, rue Saint-Victor - 75005 Paris
ACCESS
RER (Express Commuter Train):
Station Saint-Michel Notre-Dame, line B
Car Parks :
PARKING MAUBERT
COLLÈGE DES BERNARDINS
37 boulevard St Germain 75005 Paris
PARKING LAGRANGE MAUBERT
15 rue Lagrange 75005 Paris
THE BEST FARE
FOR YOUR AIRLINE TICKET
Attractive discounts on a wide range of fares on all
Air France and KLM flights worldwide
Event ID Code to keep for the booking: 23820AF
Valid for travel from 21/05/2016 to 02/06/2016
USEFUL WEB SITES
RATP (CITY TRANSPORT NETWORK):
www.ratp.com
MAPPY (ITINERARIES/DIRECTIONS):
www.mappy.com
PARIS TOURIST OFFICE:
www.parisinfo.com
AIR FRANCE:
www.airfrance.com
SNCF (FRENCH RAILWAYS NETWORK):
www.voyages-sncf.com
ADP (PARIS AIRPORTS):
www.aeroportsdeparis.fr
WIFI
Free wifi is available for the duration of the congress
Access code: ESPD
Password: espd2016
GPS coordinates: 48.8486110 2.3504103
Subway: Station Jussieu: line 7
Stations Maubert-Mutualité, Cardinal Lemoine: line 10
Bus: Station Monge - Mutualité: lines 63, 86, 87
Station Maubert - Mutualité: lines 24, 63, 47
Station Cardinal Lemoine - Monge: line 89
Station Jussieu: line 67
39
REGISTRATION DESK HOURS :
Wednesday May 25th, 2016 from 16:00 to 19:00
Thursday May 26th, 2016 from 07:00 to 18:30
Friday May 27th, 2016 from 07:00 to 18:30
Saturday May 28th, 2016 from 07:00 to 13:30
CLOAKROOM:
PREVIEW ROOM HOURS :
Preview room is situated on level 5 room: Sully
SPONSORED BY
The cloakroom is situated on Level - 1
ABSTRACTS :
Abstracts will be published in the Journal Pediatric
Dermatology.
CERTIFICATE OF ATTENDANCE :
EXHIBITION HOURS :
Wednesday May 25 , 2016 from 20:00 to 21:00
th
All registered participants will receive a certificate of
attendance after the congress.
TAXI
G7: 3607
+33 1 47 39 47 39
REGISTRATION ON SITE:
All indicate rates below include a VAT of 20% at current rate at the day of printing.
REGISTRATION CATEGORIES
ON SITE REGISTRATION AS FROM MAY 25TH, 2016
Member ESPD
600,00 €
Non Member
700,00 €
Student*
300,00 €
Doctor in training*
400,00 €
Accompanying Person(s)
200,00 €
* Registration must be accompanied by a written confirmation from the Head of Department or a student card.
DELEGATES’ REGISTRATION FEES INCLUDE: • Admission to scientific sessions and satellite
symposia
• Congress bag with congress documents
• Final programme
• Certificate of attendance (after the congress)
• Opening ceremony on Wednesday, 25th May
• Admission to exhibition
ACCOMPANYING PERSONS’ REGISTRATION
FEES INCLUDE:
• Opening ceremony on Wednesday, 25th May
• Admission to exhibition TERMS OF PAYMENT
ESPD 2016 has given mandate to MCI for the
organization of the 13th European Society for
Pediatric Dermatology and therefore to act and
receive the fees on its behalf.
40
Payments may be made either:
• by cheque payable in France to the order
of ESPD 2016 - MCI
• by credit card: VISA, EURO/MASTER CARD
or AMEX only (NO other cards accepted)
• by cash
CANCELLATION POLICY FOR INDIVIDUAL
REGISTRATION & RESERVATIONS
All cancellations must be notified in writing (by mail
or e-mail) to the Congress Office according to the
following conditions and reimbursement will be
processed AFTER the Congress.
Requests for refunds made after July 15th, 2016
will not be considered:
• Up to March 31st, 2016: reimbursement of 50%
of the fees paid
• After March 31st, 2016: no refund.
40
SATELLITE SYMPOSIUM
®
Thursday, May 26th
13:00 - 14:00
Room St Victor
Evidence-based care practices
and guidelines on infant skin care
Chair: Pr Alain TAIEB, Bordeaux, France
SCIENTIFIC PROGRAM
• Skin characteristics of the newborn
Dr Dirk VAN GYSEL, Aalst, Belgium
• Skin care in newborn infants-Latest update
Dr Ioanna THANOPOULOU, Athens, Greece
VIVACTIS
ADVANCE
• Skin care in children with barrier dysfunction
Dr Barbara KUNZ, Hamburg, Germany
ACCOMMODATION
LIST OF HOTELS
CAT.
HOTEL
TYPE
SINGLE
ROOM
DOUBLE
ROOM
BREAKFAST
CITY
TAXE
NEAREST
METRO
4*
PULLMAN
MONTPARNASSE
Standard
236,48 €
264,96 €
Incl.
Incl.
Montparnasse
Bienvenue
(line 4, 6, 12
and 13)
4*
CONCORDE
MONTPARNASSE
Incl.
Montparnasse
Bienvenue
(line 4, 6, 12
and 13)
3
4*
NOVOTEL PARIS
MONTPARNASSE
Standard
227,48 €
247,96 €
Incl.
Incl.
Montparnasse
Bienvenue
(line 4, 6, 12
and 13)
4
4*
MERCURE GARE
MONTPARNASSE
Standard
227,48 €
247,96 €
Incl.
Incl.
Gaité
(line 13)
5
3*
MERCURE LA
SORBONNE
Standard
311,48 €
318,96 €
Incl.
Incl.
Maubert
Mutualité
(line 10)
6
3*
BEST WESTERN
JARDIN DE
CLUNY
Superior
230,00 €
250,00 €
Incl.
Incl.
Maubert
Mutualité
(line 10)
7
3*
ELYSA
LUXEMBOURG
Classic
275,00 €
290,00 €
Incl.
Incl.
Luxembourg
(line RER C)
7
3*
ELYSA
LUXEMBOURG
Superior
305,00 €
320,00 €
Incl.
Incl.
Luxembourg
(line RER C)
8
3*
GRAND HOTEL
SAINT MICHEL
Standard
337,48 €
354,96 €
Incl.
Incl.
Luxembourg
(line RER C)
1
2
Standard
212,48 €
224,96 €
Incl.
All rates are indicated in Euros (€) per night and per room and include VAT tax and service, breakfast and
city tax.
Reservations for the hotels listed above must be made through the Congress Office to guarantee the
indicated rates.
According to their location, some hotels are at walking distance from the Congress venue, some other a few
minutes away by public transportation. There will be no shuttle services provided by the Congress between
the official hotels and the “Maison de la Mutualité”.
42
A PAYMENT of the FULL STAY will be requested for all hotel reservations. It will be automatically deducted
from the total amount of your hotel bill when leaving.
Cancellation conditions for hotel reservations :
All cancellations must be notified in writing (by mail or e-mail) to the Congress Office according to the
following conditions and reimbursement will be processed AFTER the Congress. Requests for refunds
made after July 15th, 2016 will not be considered:
• Up to February 15th, 2016: reimbursement of 50% of the fees paid
• After February 15th, 2016: no refund.
For cancellation conditions for group reservations, please contact the Congress Office.
MAP OF HOTELS
Mercure La Sorbonne
5
Grand Hotel Saint Michel
8
7
Best Western
Jardin De Cluny
6
Congress venue:
Elysa Luxembourg
Mercure Gare Montparnasse
Novotel
Paris Montparnasse
3
4
2
1
Concorde
Montparnasse
Pullman
Montparnasse
43
CONGRESS CENTER FLOOR PLAN
LEVEL 5
POSTERS AREA
ROOMS: SORBONNE - BIEVRE
SOUFFLOT - PANTHEON - SULLY
LEVEL 3
EXHIBITION
ROOMS: MAUBERT
SAINT VICTOR - ODEON
GROUND FLOOR
REGISTRATION DESK
LEVEL -1
CLOAKROOM
AMPHITHEATER
44
LEVEL 3
EXHIBITION AREA
ROOM: MAUBERT
AMPHITHEATER
LEVEL -1
PATIENT SUPPORT
GROUPS
ROOM: ODEON
ROOM:
SAINT-VICTOR
LEVEL 5
ROOM:
SORBONNE
ROOM:
BIÈVRE
POSTER AREA
SESSION 2
ROOM:
PONTOISE
POSTER AREA
SESSION 1
ROOM: SALLE
DU CONSEIL
E POSTER
AREA
POSTER AREA
SESSION 3
ROOM:
POISSY
PREVIEW
ROOM
SULLY
45
ACCESS TO THE MAISON DE LA MUTUALITÉ
Ru
e
de
P
ont
ois
e
46
SPONSORS ACKNOWLEDGEMENT
The Organising Committee would like to thank
the following companies for their support:
PLATINUM SPONSOR
GOLD SPONSORS
SILVER SPONSORS
Preliminary programme
& Call for abstracts
BRONZE SPONSOR
www.espd2016.com
The 13th ESPD Congress (ESPD 2016)
is endorsed by the European Society for Pediatric Dermatology
PEDIATRIC DERMATOLOGY
47
Keynote Speakers

Ilona Frieden
(San Francisco, USA)

Raoul CM Hennekam
(Amsterdam, Netherlands)

Sinead Langan

Jemima Mellerio

Peter Robinson
(Berlin, Germany)

Antonio Torrelo
(Madrid, Spain)
espd2018.com

Final programme

Transcription

Similar documents

I`m helping to end MS by participating in the 2016 Jayman BUILT MS

The Board of Directors of Qatar Fuel (WOQOD) is pleased to invite

Thomas Quasthoff. - Philharmonie de Paris

5 `S` Training Program at ABV-IIITM, Gwalior on 21.07.2016

Beyond the doors of the Stollery`s pediatric emergency department

4 star ALOE HOTEL, PAPHOS

french leader in the information about higher education

TRADE SHOW PASS wsrca.com 1-800-725-0333

loyola institute for ministry on-campus open house thursday, may 12

HALF OFF - Bavarian Inn